187 lines
154 KiB
Text
187 lines
154 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK604195">
|
|
<meta name="ncbi_domain" content="statpearls">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK604195/?report=reader">
|
|
<meta name="ncbi_pagename" content="Vertical Transplacental Infections - StatPearls - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Vertical Transplacental Infections - StatPearls - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="StatPearls [Internet]">
|
|
<meta name="citation_title" content="Vertical Transplacental Infections">
|
|
<meta name="citation_publisher" content="StatPearls Publishing">
|
|
<meta name="citation_date" content="2024/08/16">
|
|
<meta name="citation_author" content="James M. McCluskey">
|
|
<meta name="citation_author" content="Alice I. Sato">
|
|
<meta name="citation_pmid" content="38861626">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK604195/">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Vertical Transplacental Infections">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="StatPearls Publishing">
|
|
<meta name="DC.Contributor" content="James M. McCluskey">
|
|
<meta name="DC.Contributor" content="Alice I. Sato">
|
|
<meta name="DC.Date" content="2024/08/16">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK604195/">
|
|
<meta name="description" content="As opposed to horizontal transmission between individuals in a population, vertical transmission of an infectious agent is generally defined as transmission from a pregnant individual to their fetus. Horizontal transmission during pregnancy is frequently examined based on timing (antenatal, perinatal, or postnatal); more specific considerations involve viral transplacental infections.[1] Vertical antenatal and in-utero infections refer to the same general mechanism of infection, although the particular pathophysiologic mechanisms will vary with the infectious agent. Viral transplacental infections represent a critical category of maternal-fetal health concerns, with the capacity to traverse the placental barrier and adversely affect the developing fetus, leading to a range of outcomes, from mild disease to severe congenital anomalies or fetal death.">
|
|
<meta name="og:title" content="Vertical Transplacental Infections">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="As opposed to horizontal transmission between individuals in a population, vertical transmission of an infectious agent is generally defined as transmission from a pregnant individual to their fetus. Horizontal transmission during pregnancy is frequently examined based on timing (antenatal, perinatal, or postnatal); more specific considerations involve viral transplacental infections.[1] Vertical antenatal and in-utero infections refer to the same general mechanism of infection, although the particular pathophysiologic mechanisms will vary with the infectious agent. Viral transplacental infections represent a critical category of maternal-fetal health concerns, with the capacity to traverse the placental barrier and adversely affect the developing fetus, leading to a range of outcomes, from mild disease to severe congenital anomalies or fetal death.">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK604195/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-statpearls-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/statpearls/article-161800/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK604195/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8E3D6D7C9222A10000000000190016.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK604195/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"></div><div class="body"><div class="t">Vertical Transplacental Infections</div><div class="j">StatPearls [Internet]</div></div><div class="tail"></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-cmap-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK604195/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK604195/&text=Vertical%20Transplacental%20Infections"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-cmap-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">In Page Navigation</div></div><div class="cnt lol f1"><a href="/books/n/statpearls/?report=reader">Title Information</a><a href="/books/n/statpearls/toc/?report=reader">Table of Contents Page</a><a href="#_NBK604195_">Vertical Transplacental Infections</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK604195/?report=classic">Switch to classic view</a><a href="/books/NBK604195/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK604195%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8E3D6D7C9222A10000000000190016.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK604195_"><span class="title" itemprop="name">Vertical Transplacental Infections</span></h1><p class="contribs">McCluskey JM, Sato AI.</p><p class="fm-aai"><a href="#_NBK604195_pubdet_">Publication Details</a></p></div></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="article-161800.s1"><h2 id="_article-161800_s1_">Continuing Education Activity</h2><p>Vertical transplacental infections pose a significant risk in maternal-fetal and pediatric health, as various pathogens can cross the placental barrier and adversely affect the developing fetus. These infections include those caused by viruses such as rubella, cytomegalovirus, herpes simplex, parvovirus B19, hepatitis C, varicella-zoster, and Zika, as well as other pathogens like <i>Toxoplasma gondii</i>, <i>Listeria monocytogenes</i>, and <i>Treponema pallidum</i>. The outcomes of these infections vary, ranging from mild illness to severe congenital anomalies, fetal death, or chronic conditions that persist into infancy. The timing of the antenatal infection, along with the specific pathogen involved, greatly influences the severity and type of outcomes, necessitating precise and timely interventions.</p><p>Participants in this course gain a comprehensive understanding of the common viral and bacterial etiologies responsible for vertical transplacental infections, along with the diagnostic and management strategies crucial for improving patient outcomes. The course emphasizes the importance of early detection and intervention, including the use of appropriate antibiotics, antivirals, and fetal monitoring techniques. By collaborating with an interprofessional team, healthcare professionals enhance patient outcomes through a coordinated approach that includes infection prevention, patient counseling, and the implementation of timely interventions. This collaborative model ensures that care is holistic, addressing the needs of both the mother and the fetus, ultimately leading to better health outcomes.</p><p>
|
|
<b>Objectives:</b>
|
|
<ul><li class="half_rhythm"><div>Identify the most common pathogens responsible for vertical transplacental infections, including rubella, cytomegalovirus, herpes simplex virus, and others, to ensure accurate diagnosis and timely management.</div></li><li class="half_rhythm"><div>Implement standardized protocols and algorithms for the early identification, risk assessment, and management of vertical transplacental infections to reduce practice variability and improve care consistency.</div></li><li class="half_rhythm"><div>Select the appropriate antimicrobial or antiviral therapy based on the pathogen identified, gestational age, and current best practices to ensure effective treatment while minimizing risks to the fetus.</div></li><li class="half_rhythm"><div>Develop and implement interprofessional team strategies to improve care coordination and outcomes for patients with vertical transplacental infections.</div></li></ul>
|
|
<a href="https://www.statpearls.com/account/trialuserreg/?articleid=161800&utm_source=pubmed&utm_campaign=reviews&utm_content=161800" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Access free multiple choice questions on this topic.</a>
|
|
</p></div><div id="article-161800.s2"><h2 id="_article-161800_s2_">Introduction</h2><p>As opposed to horizontal transmission between individuals in a population, vertical transmission of an infectious agent is generally defined as transmission from a pregnant individual to their fetus. Horizontal transmission during pregnancy is frequently examined based on timing (antenatal, perinatal, or postnatal); more specific considerations involve viral transplacental infections.<a class="bibr" href="#article-161800.r1" rid="article-161800.r1">[1]</a> Vertical antenatal and in-utero infections refer to the same general mechanism of infection, although the particular pathophysiologic mechanisms will vary with the infectious agent. Viral transplacental infections represent a critical category of maternal-fetal health concerns, with the capacity to traverse the placental barrier and adversely affect the developing fetus, leading to a range of outcomes, from mild disease to severe congenital anomalies or fetal death.</p><p>Infectious agents that can cross the placenta include those historically described by "ToRCHes" (toxoplasmosis, other [hepatitis B virus and syphilis], rubella, cytomegalovirus, and herpes simplex virus). However, <i>Listeria</i>, human immunodeficiency virus (HIV), parvovirus B19, varicella-zoster virus, hepatitis C virus, and Zika virus are also known to cause transplacental infections. Each infection can have profound implications for fetal development, with risks varying based on the timing of infection during pregnancy and the specific pathogen involved. See StatPearls' companion references, " <a href="https://www.statpearls.com/point-of-care/17639" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Antepartum infections</a>," "<a href="https://www.statpearls.com/point-of-care/22931" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">HIV in Pregnancy</a>," and "<a href="https://www.statpearls.com/point-of-care/91623" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Pregnancy and Viral Hepatitis</a>," for more information on vertically transmitted infections and associated intrapartum issues.</p><p>Please note that the terms "maternal" and "mother" in this activity refer to the birthing parent and are not meant to exclude other birthing parents.</p></div><div id="article-161800.s3"><h2 id="_article-161800_s3_">Etiology</h2><p>Maternal infection with the pathogen precedes fetal acquisition of a transplacental infection. Various transmission routes can result in maternal infection, including sexual contact, consumption of contaminated food, or acquisition from vectors such as mosquitos or ticks. The mechanisms by which pathogens traverse the placental barrier to affect the developing fetus are not fully understood and differ between pathogens. Specific placental cell types play a crucial role in this process, including cytotrophoblasts and syncytiotrophoblasts, which act as the primary barrier between the maternal and fetal blood. Extravillous trophoblasts invade maternal tissues, establishing a connection with the maternal immune system.<a class="bibr" href="#article-161800.r1" rid="article-161800.r1">[1]</a> Please see StatPearls' companion reference, "<a href="https://www.statpearls.com/point-of-care/136052" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Immunology at the Maternal-Fetal Interface</a>," for additional information. Generally, after a pregnant individual acquires a primary infection, the pathogen will circulate in the maternal bloodstream and traverse the placenta by infecting several of these interface cell types. Alternatively, in the presence of multiple infectious agents or placental trauma, weakening of the placental barrier may permit maternal and fetal blood mixing that leads to fetal infection.</p><p>
|
|
<b>Sexually Transmitted Infections</b>
|
|
</p><p>Syphilis is the clinical manifestation of infection with the spirochete <i>Treponema pallidum,</i> and maternal infection can result in fetal infection.<a class="bibr" href="#article-161800.r2" rid="article-161800.r2">[2]</a> Previously, experts believed that congenital syphilis could only be acquired after the first trimester of pregnancy.<a class="bibr" href="#article-161800.r3" rid="article-161800.r3">[3]</a> However, it is now widely accepted that maternal syphilis at any stage (primary, secondary, latent, tertiary) carries the potential for congenital syphilis infection throughout the pregnancy. Congenital infection is typically more severe when acquired later in gestation.<a class="bibr" href="#article-161800.r2" rid="article-161800.r2">[2]</a><a class="bibr" href="#article-161800.r3" rid="article-161800.r3">[3]</a><a class="bibr" href="#article-161800.r4" rid="article-161800.r4">[4]</a><a class="bibr" href="#article-161800.r2" rid="article-161800.r2">[2]</a><a class="bibr" href="#article-161800.r5" rid="article-161800.r5">[5]</a> Please see StatPearls' companion reference, <a href="https://www.statpearls.com/point-of-care/29822" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">"Syphilis,"</a> for more detailed information on syphilis in nonpregnant individuals. Please see StatPearl's companion reference, <a href="https://www.statpearls.com/point-of-care/19869" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">"Congenital and Maternal Syphilis</a>," for additional details on syphilis in pregnancy.</p><p>Human herpesviruses 1 and 2 (HSV-1, HSV-2) may also be sexually transmitted. Approximately 5% of cases of herpetic infections are transmitted transplacentally. Although transplacental infection typically results in more severe fetal infections, perinatal acquisition is much more common (85%). Fetal outcomes are thought to be better when infections with alphaherpesvirinae are acquired at an earlier gestational age.<a class="bibr" href="#article-161800.r6" rid="article-161800.r6">[6]</a><a class="bibr" href="#article-161800.r7" rid="article-161800.r7">[7]</a><a class="bibr" href="#article-161800.r8" rid="article-161800.r8">[8]</a> Please see StatPearl's companion reference, <a href="https://www.statpearls.com/point-of-care/22931" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">"</a><a href="https://www.statpearls.com/point-of-care/19855" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Congenital Herpes Simplex</a>," for additional information. </p><p>Human immunodeficiency viruses 1 and 2 (HIV-1, HIV-2), hepatitis B and C viruses (HBV, HCV), can be maternally acquired via sexual contact, intravenous drug use, or other blood or body fluid exposures. Vertical transmission of HIV is thought to occur primarily in the intrapartum period.<a class="bibr" href="#article-161800.r9" rid="article-161800.r9">[9]</a> Throughout pregnancy, the risk of fetal acquisition of HIV is correlated with the maternal HIV viral load. Results from a recent study demonstrated no vertical transmission of HIV when the viral load was undetectable at the time of delivery.<a class="bibr" href="#article-161800.r10" rid="article-161800.r10">[10]</a> The mechanism of in-utero HIV transmission is incompletely understood but estimated to account for 5% to 10% of cases, with suspected mechanisms involving infection of the trophoblasts and transcytosis with HIV in the third trimester.<a class="bibr" href="#article-161800.r9" rid="article-161800.r9">[9]</a> Please see StatPearl's companion reference <a href="https://www.statpearls.com/point-of-care/22931" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">"HIV in Pregnancy"</a> for additional information.</p><p>A minority of cases of HBV are vertically transmitted by the transplacental route (3.7%).<a class="bibr" href="#article-161800.r11" rid="article-161800.r11">[11]</a> According to the results from a study, the suspected pathophysiologic mechanisms of viral transmission center around maternal hepatitis B e antigen positivity, threatened preterm labor, and HBV in the villous capillary endothelial cells of the placenta.<a class="bibr" href="#article-161800.r11" rid="article-161800.r11">[11]</a> The results also demonstrated that transplacental leakage of maternal blood can cause intrauterine infection.<a class="bibr" href="#article-161800.r11" rid="article-161800.r11">[11]</a> Emerging evidence also shows that HBV infection of maternal peripheral blood mononuclear cells plays a critical role in intrauterine infection.<a class="bibr" href="#article-161800.r12" rid="article-161800.r12">[12]</a> </p><p>These peripheral mononuclear cells are also involved in the transmission of HCV to the fetus; transmission is also affected by maternal HCV viremia and coinfection with HIV.<a class="bibr" href="#article-161800.r13" rid="article-161800.r13">[13]</a><a class="bibr" href="#article-161800.r14" rid="article-161800.r14">[14]</a> HCV is unique because intrauterine infection, rather than perinatal transmission, is thought to cause most vertical infections. Furthermore, fetal infection is primarily established in the second or third trimester, though transmission can rarely occur in the first trimester.<a class="bibr" href="#article-161800.r15" rid="article-161800.r15">[15]</a> Please see StatPearl's companion reference, <a href="https://www.statpearls.com/point-of-care/91623" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">"Pregnancy and Viral Hepatitis,</a>" for additional details on transmission.</p><p>Cytomegalovirus (CMV) is often acquired when individuals are in close contact with others, particularly young children and their body fluids.<a class="bibr" href="#article-161800.r16" rid="article-161800.r16">[16]</a> CMV is suspected to be transmitted via sexual contact as well. CMV is very common; the seropositivity of women of childbearing age is estimated to be 86% globally.<a class="bibr" href="#article-161800.r17" rid="article-161800.r17">[17]</a> Thus, primary CMV infection of the birthing parent during pregnancy is less common, but when it occurs, fetal outcomes are significantly worse compared to secondary maternal infection,<a class="bibr" href="#article-161800.r18" rid="article-161800.r18">[18]</a> though reinfection with new strains of CMV in seroimmune women can lead to congenital CMV infection.<a class="bibr" href="#article-161800.r19" rid="article-161800.r19">[19]</a> Fetal outcomes are also worse when CMV is acquired early in the pregnancy.<a class="bibr" href="#article-161800.r20" rid="article-161800.r20">[20]</a> Though CMV is known to infect villous cytotrophoblasts and blood vessels in the villous core, even without actual fetal transmission, this damage to the placenta can also cause intrauterine growth restriction.<a class="bibr" href="#article-161800.r21" rid="article-161800.r21">[21]</a> Please see StatPearl's companion reference, "<a href="https://www.statpearls.com/point-of-care/19849" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Congenital Cytomegalovirus Infection,</a>" for additional information.</p><p>
|
|
<b>Foodborne Illness </b>
|
|
</p><p>The consumption of contaminated food by the pregnant individual is a well-known route for acquiring toxoplasmosis, caused by the parasitic protozoan <i>Toxoplasma gondii</i>, and listeriosis, caused by the gram-positive facultative intracellular bacillus, <i>Listeria monocytogenes</i>. Pregnant individuals can acquire toxoplasmosis by consuming <i>T gondii</i> oocysts in contaminated food, water, or soil (eg, cat litter) or by ingestion of tissue cysts in infected meat.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> Oocysts and tachyzoites are other forms of <i>T gondii</i>, the latter of which is the mobile form known to infect a fetus transplacentally.<a class="bibr" href="#article-161800.r23" rid="article-161800.r23">[23]</a> Other sources of congenital <i>T gondii </i>infection include reactivation of latent disease in a pregnant individual or reinfection with a different, more virulent strain.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> Please see StatPearl's companion references, "<a href="https://www.statpearls.com/point-of-care/95334" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Toxoplasmosis</a>" and "<a href="https://www.statpearls.com/point-of-care/19872" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Congenital Toxoplasmosis</a>," for further discussion.</p><p>Listeriosis can be contracted from eating foods made with unpasteurized milk, deli meats, and ready-to-eat food that has not been properly cooked or is contaminated after cooking.<a class="bibr" href="#article-161800.r24" rid="article-161800.r24">[24]</a><a class="bibr" href="#article-161800.r25" rid="article-161800.r25">[25]</a> <i>L monocytogenes</i> is found in farms and on food processing equipment, and survives and grows in cold, high salt, and low pH conditions.<a class="bibr" href="#article-161800.r26" rid="article-161800.r26">[26]</a> It has specific tropism for the placenta, with significantly increased fetal death occurring when infection is established before 29 weeks gestation.<a class="bibr" href="#article-161800.r24" rid="article-161800.r24">[24]</a><a class="bibr" href="#article-161800.r27" rid="article-161800.r27">[27]</a> </p><p>
|
|
<b>Illness Acquired Via Airborne Transmission</b>
|
|
</p><p>Human parvovirus B19 (B19V) is the etiologic agent of the common childhood disease erythema infectiosum and is spread via respiratory droplets. Infection with B19V most frequently occurs among those with repeated contact with school-aged children.<a class="bibr" href="#article-161800.r28" rid="article-161800.r28">[28]</a><a class="bibr" href="#article-161800.r29" rid="article-161800.r29">[29]</a> Often the infected pregnant individual is asymptomatic. B19V infection of endothelial cells within placental villi plays the primary role in transplacental infection of the fetus.<a class="bibr" href="#article-161800.r30" rid="article-161800.r30">[30]</a> When parvovirus B19 fetal infection occurs before 20 weeks gestation, the infection has been shown to disproportionally result in the most severe complications, including nonimmune hydrops fetalis and fetal death.<a class="bibr" href="#article-161800.r29" rid="article-161800.r29">[29]</a> </p><p>The rubella virus also spreads via respiratory droplets. The overall incidence of rubella is low due to widespread vaccination, with rubella elimination verified in 98 (51%) of 194 countries by 2022.<a class="bibr" href="#article-161800.r31" rid="article-161800.r31">[31]</a> Due to the rarity of fetal rubella infection, the pathophysiologic mechanism is unclear; emboli of necrotized endothelial cells from the infected chorion are suspected.<a class="bibr" href="#article-161800.r32" rid="article-161800.r32">[32]</a> If a pregnant individual acquires rubella within the first 12 weeks of gestation, severe consequences for the developing fetus can result. Maternal infection in the second and third trimesters carries significantly less risk to the fetus.<a class="bibr" href="#article-161800.r33" rid="article-161800.r33">[33]</a> Please see StatPearls' companion reference, "<a href="https://www.statpearls.com/point-of-care/19868" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Congenital Rubella Syndrome,</a>" for additional information.</p><p>Varicella-zoster virus (VZV), or human herpesvirus 3, is the etiologic agent of chickenpox; reactivation of VZV causes shingles. VZV primarily spreads through respiratory droplets or direct contact with blister fluid. Primary infection with VZV during pregnancy is now rare secondary to vaccination; individuals of childbearing age have a high seroprevalence, especially in the United States.<a class="bibr" href="#article-161800.r7" rid="article-161800.r7">[7]</a><a class="bibr" href="#article-161800.r34" rid="article-161800.r34">[34]</a> Primary VZV infection during pregnancy, rather than secondary infection or reactivation, is believed to lead to congenital varicella syndrome.<a class="bibr" href="#article-161800.r35" rid="article-161800.r35">[35]</a> Vertical transmission of VZV is thought to be transplacental; the mechanism is unknown. Primary acquisition of VZV by pregnant individuals before an estimated gestational age of 20 weeks poses the highest risk of subsequent congenital varicella syndrome (0.91%). Congenital varicella syndrome has been reported following maternal primary varicella infection between an estimated gestational age of 20 and 28 weeks and recently as late as 36 weeks.<a class="bibr" href="#article-161800.r36" rid="article-161800.r36">[36]</a><a class="bibr" href="#article-161800.r37" rid="article-161800.r37">[37]</a> Please see StatPearls' companion reference, "<a href="https://www.statpearls.com/point-of-care/130914" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Congenital Varicella Syndrome</a>," for additional information.</p><p>
|
|
<b>Vector-Borne Disease</b>
|
|
</p><p>Zika virus (ZIKV) is a vector-borne disease with maternal-fetal relevance. ZIKV is transmitted primarily through bites from infected <i>Aedes</i> mosquitoes and through sexual contact with infected individuals, blood transfusions, and contact with bodily fluids. Once a pregnant individual is infected, ZIKV is suspected to infect trophoblasts, cross the placental and blood-brain barriers, and infect brain endothelial cells.<a class="bibr" href="#article-161800.r38" rid="article-161800.r38">[38]</a> In addition, ZIKV appears to disrupt the permeability of tight junctions, permitting paracellular transplacental but not blood-brain barrier transmission.<a class="bibr" href="#article-161800.r38" rid="article-161800.r38">[38]</a></p></div><div id="article-161800.s4"><h2 id="_article-161800_s4_">Epidemiology</h2><p>Not all epidemiologic studies separate infections acquired transplacentally from infections that may be acquired perinatally. The following discussion focuses on the epidemiology of vertically transmitted infectious agents thought to be acquired primarily by the transplacental route.</p><p>
|
|
<b>Syphilis</b>
|
|
</p><p>Incidence rates of congenital syphilis are highest in low- and middle-income countries, while in high-income countries, cases have resurged over the past decade.<a class="bibr" href="#article-161800.r39" rid="article-161800.r39">[39]</a> Between 2012 and 2016, 1120 cases of congenital syphilis per 100,000 live births were diagnosed in Africa, 19 cases per 100,000 were diagnosed in Europe, 339 per 100,000 were diagnosed in the Americas, and 640 per 100,000 were identified in the Eastern Mediterranean region.<a class="bibr" href="#article-161800.r39" rid="article-161800.r39">[39]</a> In 2016, the global incidence of congenital syphilis was estimated to be 473 cases per 100,000 live births; this was nearly unchanged in 2020, estimated at 425 cases per 100,000.<a class="bibr" href="#article-161800.r40" rid="article-161800.r40">[40]</a><a class="bibr" href="#article-161800.r39" rid="article-161800.r39">[39]</a> In the United States, the absolute number of congenital syphilis cases increased from 941 in 2017 to 2677 in 2021. This data likely underestimates the true disease burden due to unrecognized or asymptomatic infection, among other reasons.<a class="bibr" href="#article-161800.r39" rid="article-161800.r39">[39]</a> The reasons behind increasing case numbers are multifactorial, but decreased testing during the COVID-19 pandemic plays a key role.<a class="bibr" href="#article-161800.r41" rid="article-161800.r41">[41]</a></p><p>
|
|
<b>Hepatitis C Virus</b>
|
|
</p><p>Geographically, the burden of HCV infection is similar to syphilis, with a pooled prevalence of HCV among pregnant women in low-income countries (2.7%) higher than that of lower-middle-income countries (2.3%); both are higher than the global prevalence of 1.0%. However, unlike syphilis, the prevalence of HCV has decreased over time, with a prevalence of 0.8% reported from 2001 to 2010 and 0.5% from 2011 to 2020. Of children born to HCV antibody-positive and ribonucleic acid-positive women, about 5.8% go on to develop HCV infection, while about 10.8% develop HCV when they are born to mothers who are dual HCV- and HIV-positive.<a class="bibr" href="#article-161800.r14" rid="article-161800.r14">[14]</a></p><p>
|
|
<b>Toxoplasmosis</b>
|
|
</p><p>The most robust epidemiologic data for congenital toxoplasmosis comes from France and Brazil, where surveillance programs exist for pregnant individuals. In France, 2 to 3 infants per 10,000 live births were estimated to be infected, while in Brazil, this number is estimated to be between 1 in 622 to 1 in 770 live births.<a class="bibr" href="#article-161800.r42" rid="article-161800.r42">[42]</a> In the United States, the prevalence of <i>T gondii</i> in women of childbearing age has decreased from 15% between 1988 and 1994 to 9% between 2009 and 2010.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> Approximately 91% of these women in the United States are at risk of primary infection with <i>T gondii</i>; in France, this number approximates 70%.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a><a class="bibr" href="#article-161800.r43" rid="article-161800.r43">[43]</a> Not all primary infections result in congenital toxoplasmosis. The risk of transmission increases significantly with infections later in pregnancy, estimated at 15%, 44%, and 71% for seroconversion occurring at 13, 26, and 37 weeks gestation, respectively.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a></p><p>
|
|
<b>Listeriosis</b>
|
|
</p><p>The incidence of listeriosis is less well-defined, and many cases likely go unreported due to a lack of severe symptoms or testing. However, a recent epidemiologic study in the United States demonstrated that the average incidence rate of pregnancy-associated listeriosis between 2004 and 2009 was 4.5 cases per 100,000.<a class="bibr" href="#article-161800.r44" rid="article-161800.r44">[44]</a> In this study, the consumption of Mexican-style soft cheeses emerged as a significant risk factor. Subsequently, Hispanic ethnicity was also identified as a notable risk factor. This same United States-based study estimated 1 listeriosis infection in every 8000 pregnancies within the Hispanic population, and nearly 1 in 3 of these cases resulted in neonatal death or fetal loss.<a class="bibr" href="#article-161800.r44" rid="article-161800.r44">[44]</a></p><p>
|
|
<b>Cytomegalovirus</b>
|
|
</p><p>Respiratory-acquired illnesses are common, and the epidemiology of congenital CMV infection reflects this. A 2007 meta-analysis reviewing the epidemiology of CMV estimated the combined birth prevalence of congenital CMV to be 0.64% when assessed in all live-born infants.<a class="bibr" href="#article-161800.r16" rid="article-161800.r16">[16]</a></p><p>
|
|
<b>Parvovirus B19</b>
|
|
</p><p>Infection with B19V occurs globally, and the susceptibility of women of childbearing age ranges from 26% to 44%, with the risk of acquiring B19V during pregnancy estimated to be 1% to 2% during endemic periods and 10% during epidemic periods.<a class="bibr" href="#article-161800.r45" rid="article-161800.r45">[45]</a> Seronegative pregnant patients who are initially exposed to the virus are estimated to transmit the infection to the fetus in approximately 17% to 35% of cases.<a class="bibr" href="#article-161800.r45" rid="article-161800.r45">[45]</a></p><p>
|
|
<b>Rubella and Varicella</b>
|
|
</p><p>The epidemiology of congenital rubella syndrome and congenital varicella syndrome has changed dramatically with widespread vaccine availability. Before the introduction of rubella vaccines, congenital rubella syndrome incidence ranged between 0.1 to 0.2 cases per 1000 live births and 0.8 to 4.0 cases per 1000 during epidemic periods.<a class="bibr" href="#article-161800.r46" rid="article-161800.r46">[46]</a> Since the vaccine's introduction, the incidence has decreased to less than 1 case per 100,000 live births.<a class="bibr" href="#article-161800.r47" rid="article-161800.r47">[47]</a> However, as of 2020, the rubella vaccine has reached only 70% of the global population, and the incidence in vaccine-limited areas remains elevated at approximately 64 per 100,000 live births.<a class="bibr" href="#article-161800.r47" rid="article-161800.r47">[47]</a><a class="bibr" href="#article-161800.r48" rid="article-161800.r48">[48]</a> Congenital varicella syndrome appears to be rare overall; results from a recent literature review found 130 cases of congenital varicella syndrome reported from 1947 to 2013.<a class="bibr" href="#article-161800.r37" rid="article-161800.r37">[37]</a> The authors estimated the incidence of congenital varicella syndrome to be 0.59% and 0.84% for women infected with varicella virus throughout pregnancy and in the first 20 weeks of gestation, respectively.<a class="bibr" href="#article-161800.r37" rid="article-161800.r37">[37]</a></p><p>
|
|
<b>Zika Virus</b>
|
|
</p><p>ZIKV stands out epidemiologically from other infectious agents because its reach is geographically bound. Before 2007, ZIKV cases were reported in Africa and Southeast Asia. In 2007, a ZIKV outbreak was reported in Yap State, Federated States of Micronesia, followed by a 2013 outbreak in French Polynesia. The virus subsequently spread to other Pacific islands and, in 2015, to Brazil and the Americas.<a class="bibr" href="#article-161800.r49" rid="article-161800.r49">[49]</a> Each of these outbreaks had varying incidence rates, and vertical transmission was suspected to occur in approximately 20% to 30% of cases, irrespective of the trimester when maternal infection occurred.<a class="bibr" href="#article-161800.r50" rid="article-161800.r50">[50]</a> A report of the 2015 Brazil outbreak had 5909 suspected cases of congenital ZIKV syndrome; of these, only 1501 underwent complete investigation, and 76 were confirmed.<a class="bibr" href="#article-161800.r51" rid="article-161800.r51">[51]</a></p></div><div id="article-161800.s5"><h2 id="_article-161800_s5_">History and Physical</h2><p>Vertical transplacental infections may cause symptoms or signs in pregnant individuals, fetuses, or neonates. Fetal signs and symptoms are typically identified via antenatal ultrasonography. The most crucial components of the medical history for all of these situations require a comprehensive interview of the pregnant or recently postpartum individual. Inquiries should focus on the risk factors for each etiologic agent, including a thorough sexual, occupational, dietary, travel, and substance use history.</p><p>If the pregnant individual is symptomatic, then a thorough physical examination should be performed in conjunction with fetal ultrasonography. Nonspecific ultrasonographic findings that may raise concern for vertical transplacental infections include but are not limited to intracranial, abdominal, and liver calcifications; microcephaly; cardiac malformations; limb deformities; hepatosplenomegaly; echogenic bowel or kidneys; ascites; cerebral ventriculomegaly; hydrops fetalis; and growth restriction.<a class="bibr" href="#article-161800.r7" rid="article-161800.r7">[7]</a><a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Nonspecific physical findings in neonates that may raise concern for vertical transplacental infections include but are not limited to fever, sepsis, low birth weight, microcephaly, cataracts, maculopapular rash, purpuric skin lesions or "blueberry muffin" lesions, petechiae, jaundice, hepatosplenomegaly, and lymphadenopathy.</p><p>Some fetal and neonatal findings are more characteristic of specific infections. Early-onset sepsis is more typical of listeriosis.<a class="bibr" href="#article-161800.r53" rid="article-161800.r53">[53]</a> Microcephaly should prompt suspicion of congenital rubella syndrome or infection with CMV, human herpesvirus 1 or 2, <i>T gondii</i>, and ZIKV.<a class="bibr" href="#article-161800.r54" rid="article-161800.r54">[54]</a> Ocular abnormalities (eg, cataracts) may indicate congenital rubella or varicella syndromes or infection with CMV or <i>T gondii</i>.<a class="bibr" href="#article-161800.r7" rid="article-161800.r7">[7]</a> Sensorineural hearing impairment, heart defects, and congenital cataracts are the most commonly presenting symptoms of congenital rubella syndrome.<a class="bibr" href="#article-161800.r48" rid="article-161800.r48">[48]</a> Microphthalmos and certain limb abnormalities (eg, hypoplastic lower extremities) are commonly seen in congenital varicella syndrome.<a class="bibr" href="#article-161800.r55" rid="article-161800.r55">[55]</a> Low birth weight or being small for gestational age are commonly associated with transplacental infections and are nonspecific.<a class="bibr" href="#article-161800.r7" rid="article-161800.r7">[7]</a> Hepatosplenomegaly is also common with transplacental infections and is nonspecific.<a class="bibr" href="#article-161800.r54" rid="article-161800.r54">[54]</a> </p><p>Neonates with CMV are most likely to have several abnormal findings (91%); an isolated finding is seen in only 8% of infants.<a class="bibr" href="#article-161800.r56" rid="article-161800.r56">[56]</a> Another study's results showed the most common finding for infants with CMV was petechiae (74%), though hydrocephalus and intracranial calcifications are typically described.<a class="bibr" href="#article-161800.r56" rid="article-161800.r56">[56]</a> The blueberry muffin rash classically raises concern for most ToRCHes infections; however, a true blueberry muffin-appearing rash is thought to be due to extramedullary erythropoiesis occurring in the skin, and rubella and CMV are the only infectious agents that have dermal erythropoiesis documented by skin biopsy.<a class="bibr" href="#article-161800.r57" rid="article-161800.r57">[57]</a></p></div><div id="article-161800.s6"><h2 id="_article-161800_s6_">Evaluation</h2><p>Diagnosing a vertical transplacental infection may require evaluating a pregnant person, neonate, or both. Standard prenatal protocols in the United States recommend routine screening for many infections capable of transplacental infection, including HIV, HBV, HCV, and syphilis, in addition to rubella and varicella immune status. In high-risk areas, <i>T gondii </i>serology is also recommended<i>.</i><a class="bibr" href="#article-161800.r58" rid="article-161800.r58">[58]</a><a class="bibr" href="#article-161800.r59" rid="article-161800.r59">[59]</a><a class="bibr" href="#article-161800.r60" rid="article-161800.r60">[60]</a><a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> These evaluations should be repeated if new risk factors develop during pregnancy. Interestingly, beyond this screening, the use of the ToRCHes screening panel is falling out of favor.<a class="bibr" href="#article-161800.r61" rid="article-161800.r61">[61]</a><a class="bibr" href="#article-161800.r62" rid="article-161800.r62">[62]</a> Risk factors primarily drive maternal and neonatal evaluation.</p><p>
|
|
<b>Syphilis</b>
|
|
</p><p>Infants born to mothers with a positive rapid plasma reagin (RPR) at any point during pregnancy should also undergo RPR testing at birth; results should be compared to the maternal titer at that time. Infants are subsequently risk-stratified by physical examination findings, neonatal and maternal RPR titers, and maternal treatment history to determine if further evaluation is indicated. Maternal treatment must be fully documented, with timing, dosing, and antibiotic used reviewed in detail. Penicillin G is the only antibiotic treatment during pregnancy known to prevent congenital syphilis.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> Further fetal evaluation may include a complete blood count, lumbar puncture, or bone radiographs to evaluate for osteolytic lesions.<a class="bibr" href="#article-161800.r64" rid="article-161800.r64">[64]</a></p><p>
|
|
<b>Hepatitis C Virus</b>
|
|
</p><p>Infant HCV evaluation should include an HCV antibody test at approximately 18 months of age or an HCV RNA polymerase chain reaction (PCR) test between 1 and 2 months of age.<a class="bibr" href="#article-161800.r65" rid="article-161800.r65">[65]</a> If HCV infection is suspected, serial monitoring of liver function with transaminases and coagulation studies is reasonable.</p><p>
|
|
<b>Toxoplasmosis</b>
|
|
</p><p>The evaluation for <i>T gondii </i>infection in a pregnant individual should include IgG and IgM serology, followed by IgG avidity testing if appropriate.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Fetal <i>T gondii </i>infection can be confirmed by polymerase chain reaction (PCR) of amniotic fluid after 18 weeks gestation, and the fetus should subsequently be followed by ultrasound at least monthly for the remainder of gestation.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a><a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Newborn <i>T gondii </i>infection can be confirmed via <i>T gondii </i>immunoglobulin (Ig)<i> </i>IgG, IgM, and IgA titers, and if the suspicion is high, blood, urine, or cerebral spinal fluid PCR should also be obtained.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> Further investigation for end-organ damage and to ensure treatment tolerance may include blood counts, liver and kidney function testing, screening for glucose-6-phosphatase dehydrogenase deficiency, head ultrasonography or computed tomography, eye examination, and hearing evaluation.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a></p><p>
|
|
<b>Listeriosis</b>
|
|
</p><p>Fever in a pregnant individual or early-onset sepsis in an infant should prompt evaluation for listeriosis with studies including blood culture, placental culture, or cerebrospinal fluid evaluation.<a class="bibr" href="#article-161800.r53" rid="article-161800.r53">[53]</a><a class="bibr" href="#article-161800.r66" rid="article-161800.r66">[66]</a></p><p>
|
|
<b>Cytomegalovirus</b>
|
|
</p><p>Abnormal findings on fetal ultrasound usually prompt CMV evaluation using IgG avidity assays combined with IgM titers or serial serologic assays.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> These assays are considered positive if seroconversion or a greater than or equal to a —4-fold increase in anti-CMV IgG titers is identified.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Congenital CMV can be detected in amniotic fluid by culture or PCR at least 6 weeks after maternal infection and after 21 weeks of gestation.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a><a class="bibr" href="#article-161800.r67" rid="article-161800.r67">[67]</a> The diagnosis of congenital cytomegalovirus is made within 21 days of birth by PCR testing of saliva (preferred), urine, or dried blood on Guthrie cards.<a class="bibr" href="#article-161800.r67" rid="article-161800.r67">[67]</a><a class="bibr" href="#article-161800.r68" rid="article-161800.r68">[68]</a> Further investigation for end-organ damage includes blood counts, liver, kidney, and coagulation testing, head ultrasonography, eye examination, and, most importantly, hearing evaluation.</p><p>
|
|
<b>Parvovirus B19</b>
|
|
</p><p>Pregnant individuals exposed to B19V should have serologic IgG and IgM evaluations performed immediately after exposure.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Those who are IgG positive and IgM negative likely have immunity from previous exposure and are not at risk of transplacental transmission.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Meanwhile, those who are IgM positive, regardless of IgG status, should be monitored for fetal infection and hydrops fetalis.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Those who are negative for IgG and IgM are susceptible to infection, and testing should be repeated in 4 weeks.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> If repeat testing demonstrates positive IgG or IgM, these individuals should be monitored for potential fetal infection and anemia by serial ultrasonography with Doppler of the middle cerebral artery or B19V PCR in amniotic fluid.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> After birth, serum B19V PCR can be obtained in neonates to confirm the diagnosis.</p><p>
|
|
<b>Rubella Virus</b>
|
|
</p><p>All pregnant individuals should undergo a rubella IgG test at the earliest prenatal visit.<a class="bibr" href="#article-161800.r69" rid="article-161800.r69">[69]</a> Positive rubella IgG antibody testing indicates immunity.<a class="bibr" href="#article-161800.r69" rid="article-161800.r69">[69]</a> Pregnant individuals who are IgG-negative and therefore susceptible to rubella infection should be monitored for signs or symptoms of rubella infection and vaccinated postpartum.<a class="bibr" href="#article-161800.r69" rid="article-161800.r69">[69]</a> A rubella IgM antibody titer can be used to diagnose acute or recent rubella infection in pregnant individuals.<a class="bibr" href="#article-161800.r69" rid="article-161800.r69">[69]</a> The laboratory evaluation for congenital rubella syndrome in a neonate can comprise rubella-specific IgM antibodies performed within 2 months of birth, rubella-specific IgG antibodies persisting at a high concentration or long duration after birth, defined as the titer not decreasing to a 2-fold dilution per month, or isolation of rubella by viral culture or detection of viral ribonucleic acid (RNA) from the nasopharynx, urine, cerebrospinal fluid (CSF), or serum or cord blood.<a class="bibr" href="#article-161800.r70" rid="article-161800.r70">[70]</a> A further investigation of the possible complications or diagnostic confirmation of congenital rubella syndrome includes reviewing documentation of maternal rubella immunity, physical examination assessing for the aforementioned features, blood counts, liver function and bilirubin testing, CSF evaluation, echocardiography, radiography of long bones, ophthalmologic evaluation, audiology evaluation, and neuroimaging by ultrasound or computed tomography.<a class="bibr" href="#article-161800.r69" rid="article-161800.r69">[69]</a><a class="bibr" href="#article-161800.r70" rid="article-161800.r70">[70]</a></p><p>
|
|
<b>Varicella Virus</b>
|
|
</p><p>Acute varicella viral skin infection, or chickenpox—in an individual of any age, pregnant or otherwise—is usually diagnosed clinically based on the finding of a classic pruritic, vesicular rash. However, if laboratory diagnosis is desired, a sample may be taken from an unroofed lesion for qualitative varicella PCR. Subsequently, fetal varicella infection can be evaluated by ultrasonography after documented acute maternal infection.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Congenital varicella syndrome criteria include the appearance of chickenpox during pregnancy, the presence of congenital skin lesions in a dermatomal distribution or neurologic defects, eye disease, limb hypoplasia, proof of intrauterine VZV infection by detection of viral deoxyribonucleic acid in the fetus, the presence of VZV-specific IgM or IgG beyond 7 months of age, and the appearance of zoster during early infancy.<a class="bibr" href="#article-161800.r37" rid="article-161800.r37">[37]</a><a class="bibr" href="#article-161800.r71" rid="article-161800.r71">[71]</a></p><p>
|
|
<b>Zika Virus</b>
|
|
</p><p>In pregnant individuals with suspected ZKIV infection or suspicious fetal ultrasound findings, specific IgM and nucleic acid testing is recommended as soon as possible, up to 12 weeks after symptom onset.<a class="bibr" href="#article-161800.r72" rid="article-161800.r72">[72]</a> If ZKIV infection is confirmed, serial fetal ultrasonographic evaluations should be obtained to monitor for the effects on the fetus.<a class="bibr" href="#article-161800.r72" rid="article-161800.r72">[72]</a> Amniocentesis is not considered beneficial for diagnostic confirmation.<a class="bibr" href="#article-161800.r72" rid="article-161800.r72">[72]</a><a class="bibr" href="#article-161800.r73" rid="article-161800.r73">[73]</a><a class="bibr" href="#article-161800.r74" rid="article-161800.r74">[74]</a> PCR and IgM enzyme-linked immunosorbent assay testing can be performed on serum and urine for neonatal testing at birth.<a class="bibr" href="#article-161800.r75" rid="article-161800.r75">[75]</a> PCR testing for ZKIV ribonucleic acid and IgM can also be performed on CSF; cord blood studies are not recommended.<a class="bibr" href="#article-161800.r75" rid="article-161800.r75">[75]</a> If the diagnosis is highly suspicious, further infant evaluation should include a head ultrasound, thorough eye examination, and hearing screen.<a class="bibr" href="#article-161800.r75" rid="article-161800.r75">[75]</a></p></div><div id="article-161800.s7"><h2 id="_article-161800_s7_">Treatment / Management</h2><p>The management of transplacental infections depends on the timing of the diagnosis (eg, antenatal or postpartum). Additionally, the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States recommendations are available at <a href="https://clinicalinfo.hiv.gov/en/guidelines" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">https://clinicalinfo.hiv.gov/en/guidelines</a>.<a class="bibr" href="#article-161800.r59" rid="article-161800.r59">[59]</a><a class="bibr" href="#article-161800.r76" rid="article-161800.r76">[76]</a><a class="bibr" href="#article-161800.r77" rid="article-161800.r77">[77]</a><a class="bibr" href="#article-161800.r78" rid="article-161800.r78">[78]</a></p><p>
|
|
<b>Syphilis</b>
|
|
</p><p>Penicillin G is the mainstay of treatment for syphilis in all persons, including pregnant individuals, neonates, and infants.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> For pregnant individuals, the recommended penicillin G regimen is based on the stage of the disease.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> Intramuscular (IM) penicillin G is recommended in all cases except for neurosyphilis, where intravenous (IV) treatment is needed.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> For primary, secondary, and early latent syphilis, a single IM dose of 2.4 million units of penicillin G is recommended.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> For late, latent, and tertiary syphilis, 7.2 million units total, administered in 3 divided doses of 2.4 million units IM weekly, is recommended.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> Finally, for neurosyphilis, including ocular and otic, 18 to 24 million units daily, administered as 3 to 4 million units IV every 4 hours or a continuous infusion for 10 to 14 days, is recommended.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> Penicillin G is the only antibiotic treatment during pregnancy known to prevent congenital syphilis; desensitization should be undertaken in the case of a penicillin allergy.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> </p><p>For infants, IV penicillin G with age-based dosing for 10 days is preferred. The standard dose according to age is 50,000 units/kg every 12 hours for neonates aged 0 to 7 days, followed by 50,000 units/kg every 8 hours starting at 8 days of age, and another adjustment after 1 month.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a> If treatment is missed for a day, the course should be restarted, and previously administered antibiotics do not count toward the total course duration.<a class="bibr" href="#article-161800.r63" rid="article-161800.r63">[63]</a></p><p>
|
|
<b>Hepatitis C Virus</b>
|
|
</p><p>No treatment options currently exist for HCV diagnosed during pregnancy.<a class="bibr" href="#article-161800.r59" rid="article-161800.r59">[59]</a> However, after birth, if the infant is also diagnosed with HCV based on the screening recommendations, treatment should be delayed until the child is 3 years or older. The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America HCV recommendations are available at <a href="https://www.hcvguidelines.org/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">https://www.hcvguidelines.org</a>.</p><p>
|
|
<b>Toxoplasmosis</b>
|
|
</p><p>In pregnant patients diagnosed with toxoplasmosis before 18 weeks gestation, treatment with spiramycin is recommended.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> If the fetus has signs of congenital toxoplasmosis, either by amniotic fluid PCR or ultrasonographic findings, treatment should be changed from spiramycin to pyrimethamine, sulfadiazine, and folinic acid for the remainder of the pregnancy.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> For fetuses without toxoplasmosis signs, spiramycin should be continued throughout gestation. For pregnant individuals diagnosed with toxoplasmosis after 18 weeks gestation, pyrimethamine, sulfadiazine, and folinic acid are preferred initially.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> If the fetus does not develop congenital toxoplasmosis as determined by amniotic fluid PCR or ultrasound findings, the pregnant individual can either continue the regimen for the remainder of pregnancy or be switched to spiramycin.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> </p><p>Treatment for neonatal toxoplasmosis is more ill-defined. Some treatment protocols for neonates include pyrimethamine, sulfadiazine, and folinic acid treatment for the first 3 weeks of life, followed by a change to spiramycin until 2 months of age, and then returning to the pyrimethamine, sulfadiazine, and folinic acid regimen until 12 months of age.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> Conversely, some treatment protocols continue the same regimens until 24 months of age, and others forgo spiramycin.<a class="bibr" href="#article-161800.r22" rid="article-161800.r22">[22]</a> Consultation with a pediatric infectious disease specialist and a retinal exam by an experienced ophthalmologist is recommended.</p><p>
|
|
<b>Listeriosis</b>
|
|
</p><p>If listeriosis is suspected or confirmed in a pregnant individual, the preferred treatment is a minimum of 14 days of high-dose intravenous ampicillin, with or without gentamicin.<a class="bibr" href="#article-161800.r66" rid="article-161800.r66">[66]</a> For patients with a penicillin allergy, trimethoprim with sulfamethoxazole is preferred.<a class="bibr" href="#article-161800.r66" rid="article-161800.r66">[66]</a> Similar regimens are recommended for infants.</p><p>
|
|
<b>Cytomegalovirus</b>
|
|
</p><p>Currently, no treatment is consistently advised for suspected or confirmed CMV infection in a pregnant individual or their fetus.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Valacyclovir does have mounting evidence supporting its use in this circumstance, but is only currently used in research settings.<a class="bibr" href="#article-161800.r67" rid="article-161800.r67">[67]</a><a class="bibr" href="#article-161800.r79" rid="article-161800.r79">[79]</a><a class="bibr" href="#article-161800.r80" rid="article-161800.r80">[80]</a> However, the use of valacyclovir is routinely recommended for moderate to severe illness in the postpartum period.<a class="bibr" href="#article-161800.r67" rid="article-161800.r67">[67]</a> Typically, treatment is recommended for at least 6 months, and antiviral therapy is not routinely recommended for asymptomatic or mild disease.<a class="bibr" href="#article-161800.r67" rid="article-161800.r67">[67]</a> For infants with isolated sensorineural hearing loss and diagnosed congenital CMV, valacyclovir started within the first 13 weeks following birth (ie, up to 12 weeks 6 days) can be offered for a limited 6-week treatment course according to the 2024 American Academy of Pediatrics Committee on Infectious Diseases,<a class="bibr" href="#article-161800.r67" rid="article-161800.r67">[67]</a><a class="bibr" href="#article-161800.r81" rid="article-161800.r81">[81]</a> though this remains an area of study and controversy. Consultation with a pediatric infectious disease specialist is recommended.</p><p>
|
|
<b>Parvovirus B19</b>
|
|
</p><p>Monitoring for hydrops fetalis and fetal anemia is recommended when managing suspected or confirmed maternal or fetal B19V infection. Fetal hematocrit obtained by blood sampling is used to monitor and determine the need for fetal transfusion.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Outside of these interventions, no B19V-specific antivirals or supportive measures are recommended.</p><p>
|
|
<b>Rubella Virus</b>
|
|
</p><p>No specific antiviral treatments are available to treat rubella infection at any age.<a class="bibr" href="#article-161800.r48" rid="article-161800.r48">[48]</a> The management of congenital rubella syndrome targets prevention with rubella vaccination and managing complications.</p><p>
|
|
<b>Varicella Virus</b>
|
|
</p><p>If varicella infection is suspected or confirmed in a pregnant individual or their fetus, oral acyclovir, when started within 24 hours of developing the varicella rash, can decrease the duration of symptoms and the number of lesions that may develop.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Intravenous acyclovir may also reduce maternal complications associated with varicella pneumonia. However, neither route of acyclovir seems to have a significant effect on reducing the fetal effects of congenital varicella syndrome.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> Pregnant patients exposed to varicella infection without evidence of immunity should be offered varicella immunoglobulin (VZIG) within 10 days of exposure.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a><a class="bibr" href="#article-161800.r82" rid="article-161800.r82">[82]</a> Despite sparse evidence, VZIG is believed to reduce the incidence of congenital varicella syndrome.<a class="bibr" href="#article-161800.r52" rid="article-161800.r52">[52]</a> After birth, acyclovir and VZIG can be used to reduce perinatal transmission opportunities.</p><p>
|
|
<b>Zika Virus</b>
|
|
</p><p>No specific antiviral treatments are available for ZIKV infection at any age.<a class="bibr" href="#article-161800.r83" rid="article-161800.r83">[83]</a> The management of congenital ZIKV infection focuses on preventing exposures and managing infection complications.</p></div><div id="article-161800.s8"><h2 id="_article-161800_s8_">Differential Diagnosis</h2><p>The differential diagnosis of a pregnant individual, fetus, or neonate with the signs and symptoms consistent with a transplacental infection is broad. Transplacental infections have a vast array of presentations and may mimic many other conditions. Diagnoses to consider include:</p><ul><li class="half_rhythm"><div>Autoimmune diseases leading to placental insufficiency and other complications</div></li><li class="half_rhythm"><div>Chromosomal abnormalities, such as Trisomy 21, Trisomy 18, and Trisomy 13, with growth restriction and structural anomalies</div></li><li class="half_rhythm"><div>Genetic syndromes</div></li><li class="half_rhythm"><div>Environmental or teratogenic exposures </div></li><li class="half_rhythm"><div>Langerhans cell histiocytosis or other hematologic or oncologic conditions <a class="bibr" href="#article-161800.r84" rid="article-161800.r84">[84]</a></div></li><li class="half_rhythm"><div>Nontransplacentally acquired infections</div></li></ul></div><div id="article-161800.s9"><h2 id="_article-161800_s9_">Prognosis</h2><p>The prognosis of transplacental infections is dictated by the timing of the diagnosis and treatment and the infection severity, which can be highly variable, making studies difficult. Additionally, prognostic studies typically focus on fetal and infant outcomes; the importance of research regarding maternal outcomes following antenatal infections should not be overlooked. </p><p>
|
|
<b>Syphilis</b>
|
|
</p><p>Results from a recent study conducted in the United States demonstrated a case fatality rate of congenital syphilis of 31%, primarily due to fetal demise in the third trimester.<a class="bibr" href="#article-161800.r85" rid="article-161800.r85">[85]</a> Beyond fetal fatality, weight-for-age was lower in patients during follow-up for congenital syphilis. However, 102 of the 120 individuals studied were healthy by the last follow-up visit.<a class="bibr" href="#article-161800.r86" rid="article-161800.r86">[86]</a></p><p>
|
|
<b>Hepatitis C Virus</b>
|
|
</p><p>The most concerning complication of HCV infection is the development of chronic HCV, leading to liver inflammation and cirrhosis, which in turn may cause other health concerns such as hepatocellular carcinoma. Fortunately, the development of chronic infection in children with HCV infection is suspected to be much lower than in adults, with 50% to 60% of infected children developing chronic disease.<a class="bibr" href="#article-161800.r87" rid="article-161800.r87">[87]</a> Similarly, the long-term prognosis is generally good, though interstudy variability is high. Some study results following patients after acquiring HCV at birth showed 5% to 10% of individuals with significant fibrosis and less than 5% with cirrhosis.<a class="bibr" href="#article-161800.r87" rid="article-161800.r87">[87]</a> </p><p>
|
|
<b>Toxoplasmosis</b>
|
|
</p><p>The prospective studies that evaluated the prognosis of congenital <i>T gondii</i> infection are quite dated, and the case fatality rate is difficult to determine. However, results from many studies have shown that congenital toxoplasmosis in neonates may be asymptomatic, but as many as 90% of untreated patients or 30% of treated patients may develop eye lesions that impair vision.<a class="bibr" href="#article-161800.r88" rid="article-161800.r88">[88]</a><a class="bibr" href="#article-161800.r89" rid="article-161800.r89">[89]</a><a class="bibr" href="#article-161800.r90" rid="article-161800.r90">[90]</a> Those treated may still develop long-term ocular or other complications; available antiparasitic drugs are only active against the tachyzoite of <i>T gondii</i> and not the bradyzoite that can remain latent in the eye and nervous systems. Only 2% of those treated were suspected to have long-term neurologic sequelae.<a class="bibr" href="#article-161800.r90" rid="article-161800.r90">[90]</a></p><p>
|
|
<b>Listeriosis</b>
|
|
</p><p>The prognosis for pregnant individuals with listeriosis is generally good, with a study whose results revealed no deaths among 107 pregnant individuals.<a class="bibr" href="#article-161800.r27" rid="article-161800.r27">[27]</a> However, the fetal and neonatal outcomes are much worse. A study including more than 200 pregnant individuals with listeriosis revealed that 1 in 5 pregnancies end in spontaneous abortion or stillbirth, and approximately two-thirds of surviving infants develop neonatal listeriosis.<a class="bibr" href="#article-161800.r91" rid="article-161800.r91">[91]</a> Of the 94 surviving infants, 62.8% recovered completely, 24.5% died, and 12.7% had long-term neurologic sequelae or other complications.<a class="bibr" href="#article-161800.r91" rid="article-161800.r91">[91]</a></p><p>
|
|
<b>Cytomegalovirus</b>
|
|
</p><p>Neonatal CMV infections have variable symptomatology, which appears predictive of outcomes. In one study, the results showed symptoms were noted in 11% of 176 CMV-infected neonates with no deaths.<a class="bibr" href="#article-161800.r92" rid="article-161800.r92">[92]</a> At follow-up, 7% had mild, 5% moderate, and 6% severe neurological sequelae. Sequelae were more frequently noted in those symptomatic at birth (42%) than asymptomatic (14%); all moderate-to-severe outcomes included in the study were identified by age 1 year. Mild sequelae comprised some hearing loss or language developmental delay; moderate sequelae included moderate hearing loss, cerebral palsy, and moderate learning difficulties. Severe sequelae were characterized by severe disability or multiple problems. Results from studies have demonstrated some evidence that treatment with ganciclovir improves audiological outcomes in congenital CMV infection. However, the optimal duration of treatment and its long-term impact is not entirely clear.<a class="bibr" href="#article-161800.r93" rid="article-161800.r93">[93]</a><a class="bibr" href="#article-161800.r94" rid="article-161800.r94">[94]</a></p><p>
|
|
<b>Parvovirus B19</b>
|
|
</p><p>Parvovirus B19 infection is estimated to contribute 0.1% to 0.8% of the overall fetal loss burden during B19V epidemics.<a class="bibr" href="#article-161800.r95" rid="article-161800.r95">[95]</a> Pregnant individuals with B19V infection have been found to have a 2.68 times higher risk of fetal loss, a 2.42 times higher risk of spontaneous abortion, and a 3.53 times higher risk of stillbirth compared with uninfected pregnant individuals.<a class="bibr" href="#article-161800.r96" rid="article-161800.r96">[96]</a> Hydrops fetalis is the leading cause of fetal morbidity and mortality in B19V infections. In a study of fetal hydrops survivors, the results showed that abnormal neurodevelopment was present in 9.5% compared to 0% of the control group.<a class="bibr" href="#article-161800.r97" rid="article-161800.r97">[97]</a></p><p>
|
|
<b>Rubella Virus</b>
|
|
</p><p>The long-term outcomes for individuals with congenital rubella syndrome are best described by a cohort of 50 patients identified by an Australian ophthalmologist in the 1930s and 1940s.<a class="bibr" href="#article-161800.r98" rid="article-161800.r98">[98]</a><a class="bibr" href="#article-161800.r99" rid="article-161800.r99">[99]</a> In this cohort, 96% were deaf, and approximately 50% had typical rubella cataracts or chorioretinopathy. Other findings included mild aortic valve sclerosis (68%), diabetes (22%), thyroid disorders (19%), early menopause (73%), and osteoporosis (12.5%), all of which had a higher prevalence than the general population. Interestingly, 25% of the patients studied were found to have elevated human leukocyte antigen (HLA)-A1, HLA-B8, or HLA-DR3 antigens associated with autoimmune conditions.</p><p>
|
|
<b>Varicella Virus </b>
|
|
</p><p>Congenital varicella syndrome is suspected to have a mortality rate up to 30% months after birth and a 15% risk of developing zoster in the first 2 years of life. However, a good long-term outcome can occur after this initial poor prognosis stage.<a class="bibr" href="#article-161800.r35" rid="article-161800.r35">[35]</a><a class="bibr" href="#article-161800.r100" rid="article-161800.r100">[100]</a></p><p>
|
|
<b>Zika Virus</b>
|
|
</p><p>Results from a Brazilian study revealed that the mortality rate among infants with confirmed or probable congenital ZIKV infection ranged from 4% to 6%.<a class="bibr" href="#article-161800.r51" rid="article-161800.r51">[51]</a> Another study evaluated a cohort of children presumed to have congenital ZIKV infection and the results found neurodevelopment or abnormal vision or hearing assessments that were below average in 31.5% aged between 7 and 32 months.<a class="bibr" href="#article-161800.r101" rid="article-161800.r101">[101]</a> Furthermore, the authors found that 12% scored greater than 2 standard deviations below average developmental scores in at least 1 domain, and 28% scored between 1 and 2 standard deviations below the mean in any neurodevelopmental domain assessed. Language function was most affected, with 35% below average. Predictors of improved neurodevelopmental outcomes were female sex, term delivery, normal findings on eye exams, and maternal infection at later gestational ages.</p></div><div id="article-161800.s10"><h2 id="_article-161800_s10_">Complications</h2><p>The complications arising from transplacental infections can be wide-ranging and severe, impacting the pregnant or postpartum individual and the fetus or infant. However, the complications that develop depend on the timing and severity of the specific infection, making the timely screening and management of these infections pivotal. (Please refer to the <b>Evaluation</b> and <b>Prognosis</b> sections for more information on infection-specific complications).</p></div><div id="article-161800.s11"><h2 id="_article-161800_s11_">Deterrence and Patient Education</h2><p>Deterrence of transplacental infections starts with comprehensive patient education on avoiding exposures that could lead to such infections. (Please refer to the <b>Etiology</b> section for more information on infection prevention.) Clinicians should emphasize the significance of regular prenatal care and follow-up, which allows for early detection and management of potential infections. Vaccination advice for preventable diseases, such as rubella and varicella, is a critical component of preconceptual counseling and care. Through proactive patient education and preventive measures, clinicians can significantly reduce the risk of transplacental infections, protecting maternal and fetal health.</p></div><div id="article-161800.s12"><h2 id="_article-161800_s12_">Enhancing Healthcare Team Outcomes </h2><p>Effective management of transplacental infections necessitates a collaborative and interprofessional approach, ensuring optimal patient care and outcomes. Central to this effort is the integration of skills and expertise from a diverse healthcare team, including obstetricians, infectious disease specialists, neonatologists, nurses, pharmacists, and public health officials, among others depending on the specific infection and its known complications. Effective interprofessional communication and clear delineation of roles and responsibilities facilitate the timely exchange of vital information, alignment of management plans, and rapid response to complications, which are especially important for several reasons.</p><p>Various specialists are involved in the care of pregnant or postpartum individuals and young patients (fetal or neonatal) with transplacental infections. Additionally, several care environments are involved, and perhaps different healthcare organizations are involved, considering that adult and pediatric care are utilized in managing transplacental infections. Healthcare professionals must stay abreast of evolving guidelines and recommendations to optimize patient outcomes and mitigate the impact of vertical transplacental infections on maternal and fetal health. Through a coordinated and interdisciplinary approach, healthcare teams can enhance patient-centered care, improve outcomes, ensure patient safety, and optimize team performance when managing vertical transplacental infections. </p></div><div id="article-161800.s13"><h2 id="_article-161800_s13_">Review Questions</h2><ul><li class="half_rhythm"><div>
|
|
<a href="https://www.statpearls.com/account/trialuserreg/?articleid=161800&utm_source=pubmed&utm_campaign=reviews&utm_content=161800" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Access free multiple choice questions on this topic.</a>
|
|
</div></li><li class="half_rhythm"><div>
|
|
<a href="https://mdsearchlight.com/infectious-disease/vertical-transplacental-infections/?utm_source=pubmedlink&utm_campaign=MDS&utm_content=161800" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Click here for a simplified version.</a>
|
|
</div></li><li class="half_rhythm"><div>
|
|
<a href="https://www.statpearls.com/articlelibrary/commentarticle/161800/?utm_source=pubmed&utm_campaign=comments&utm_content=161800" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Comment on this article.</a>
|
|
</div></li></ul></div><div id="article-161800.s14"><h2 id="_article-161800_s14_">References</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="article-161800.r1">Arora N, Sadovsky Y, Dermody TS, Coyne CB. Microbial Vertical Transmission during Human Pregnancy. <span><span class="ref-journal">Cell Host Microbe. </span>2017 May 10;<span class="ref-vol">21</span>(5):561-567.</span> [<a href="/pmc/articles/PMC6148370/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6148370</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28494237" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28494237</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>2.</dt><dd><div class="bk_ref" id="article-161800.r2">Easterlin MC, Ramanathan R, De Beritto T. Maternal-to-Fetal Transmission of Syphilis and Congenital Syphilis. <span><span class="ref-journal">Neoreviews. </span>2021 Sep;<span class="ref-vol">22</span>(9):e585-e599.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34470760" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34470760</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>3.</dt><dd><div class="bk_ref" id="article-161800.r3">Harter C, Benirschke K. Fetal syphilis in the first trimester. <span><span class="ref-journal">Am J Obstet Gynecol. </span>1976 Apr 01;<span class="ref-vol">124</span>(7):705-11.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/56895" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 56895</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>4.</dt><dd><div class="bk_ref" id="article-161800.r4">Nathan L, Bohman VR, Sanchez PJ, Leos NK, Twickler DM, Wendel GD. In utero infection with Treponema pallidum in early pregnancy. <span><span class="ref-journal">Prenat Diagn. </span>1997 Feb;<span class="ref-vol">17</span>(2):119-23.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9061759" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9061759</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>5.</dt><dd><div class="bk_ref" id="article-161800.r5">Rac MWF, Stafford IA, Eppes CS. Congenital syphilis: A contemporary update on an ancient disease. <span><span class="ref-journal">Prenat Diagn. </span>2020 Dec;<span class="ref-vol">40</span>(13):1703-1714.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32362058" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32362058</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>6.</dt><dd><div class="bk_ref" id="article-161800.r6">Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. <span><span class="ref-journal">JAMA. </span>2003 Jan 08;<span class="ref-vol">289</span>(2):203-9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12517231" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12517231</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>7.</dt><dd><div class="bk_ref" id="article-161800.r7">Auriti C, De Rose DU, Santisi A, Martini L, Piersigilli F, Bersani I, Ronchetti MP, Caforio L. Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus. <span><span class="ref-journal">Biochim Biophys Acta Mol Basis Dis. </span>2021 Oct 01;<span class="ref-vol">1867</span>(10):166198.</span> [<a href="/pmc/articles/PMC8883330/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8883330</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34118406" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34118406</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>8.</dt><dd><div class="bk_ref" id="article-161800.r8">Felker AM, Nguyen P, Kaushic C. Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model. <span><span class="ref-journal">Viruses. </span>2021 Sep 25;<span class="ref-vol">13</span>(10)</span> [<a href="/pmc/articles/PMC8538385/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8538385</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34696359" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34696359</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>9.</dt><dd><div class="bk_ref" id="article-161800.r9">Amin O, Powers J, Bricker KM, Chahroudi A. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure. <span><span class="ref-journal">Front Immunol. </span>2021;<span class="ref-vol">12</span>:757400.</span> [<a href="/pmc/articles/PMC8566974/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8566974</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34745130" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34745130</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>10.</dt><dd><div class="bk_ref" id="article-161800.r10">Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, Bui E, Pannier E, Ghosn J, Garrait V, Avettand-Fenoel V, Frange P, Warszawski J, Tubiana R. Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery. <span><span class="ref-journal">Clin Infect Dis. </span>2023 Feb 08;<span class="ref-vol">76</span>(3):e590-e598.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36037040" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 36037040</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>11.</dt><dd><div class="bk_ref" id="article-161800.r11">Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. <span><span class="ref-journal">J Med Virol. </span>2002 May;<span class="ref-vol">67</span>(1):20-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11920813" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11920813</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>12.</dt><dd><div class="bk_ref" id="article-161800.r12">Xu YY, Liu HH, Zhong YW, Liu C, Wang Y, Jia LL, Qiao F, Li XX, Zhang CF, Li SL, Li P, Song HB, Li Q. Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus. <span><span class="ref-journal">Int J Biol Sci. </span>2015;<span class="ref-vol">11</span>(3):266-73.</span> [<a href="/pmc/articles/PMC4323366/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4323366</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25678845" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25678845</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>13.</dt><dd><div class="bk_ref" id="article-161800.r13">Azzari C, Moriondo M, Indolfi G, Betti L, Gambineri E, de Martino M, Resti M. Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. <span><span class="ref-journal">J Med Virol. </span>2008 Jan;<span class="ref-vol">80</span>(1):65-71.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18041020" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18041020</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>14.</dt><dd><div class="bk_ref" id="article-161800.r14">Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. <span><span class="ref-journal">Clin Infect Dis. </span>2014 Sep 15;<span class="ref-vol">59</span>(6):765-73.</span> [<a href="/pmc/articles/PMC4144266/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4144266</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24928290" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24928290</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>15.</dt><dd><div class="bk_ref" id="article-161800.r15">Fauteux-Daniel S, Larouche A, Calderon V, Boulais J, Béland C, Ransy DG, Boucher M, Lamarre V, Lapointe N, Boucoiran I, Le Campion A, Soudeyns H. Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation <em>In Utero</em> Infection. <span><span class="ref-journal">J Virol. </span>2017 Dec 01;<span class="ref-vol">91</span>(23)</span> [<a href="/pmc/articles/PMC5686730/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5686730</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28931691" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28931691</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>16.</dt><dd><div class="bk_ref" id="article-161800.r16">Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. <span><span class="ref-journal">Rev Med Virol. </span>2007 Jul-Aug;<span class="ref-vol">17</span>(4):253-76.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17579921" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17579921</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>17.</dt><dd><div class="bk_ref" id="article-161800.r17">Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, Griffiths P. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. <span><span class="ref-journal">Rev Med Virol. </span>2019 May;<span class="ref-vol">29</span>(3):e2034.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30706584" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30706584</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>18.</dt><dd><div class="bk_ref" id="article-161800.r18">Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. <span><span class="ref-journal">N Engl J Med. </span>1992 Mar 05;<span class="ref-vol">326</span>(10):663-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1310525" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1310525</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>19.</dt><dd><div class="bk_ref" id="article-161800.r19">Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, Oliveira Pde F, Duarte G, Britt WJ. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. <span><span class="ref-journal">Am J Obstet Gynecol. </span>2010 Mar;<span class="ref-vol">202</span>(3):297.e1-8.</span> [<a href="/pmc/articles/PMC8351475/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8351475</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20060091" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20060091</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>20.</dt><dd><div class="bk_ref" id="article-161800.r20">Enders G, Daiminger A, Bäder U, Exler S, Enders M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. <span><span class="ref-journal">J Clin Virol. </span>2011 Nov;<span class="ref-vol">52</span>(3):244-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21820954" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 21820954</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>21.</dt><dd><div class="bk_ref" id="article-161800.r21">Pereira L, Petitt M, Tabata T. Cytomegalovirus infection and antibody protection of the developing placenta. <span><span class="ref-journal">Clin Infect Dis. </span>2013 Dec;<span class="ref-vol">57 Suppl 4</span>(Suppl 4):S174-7.</span> [<a href="/pmc/articles/PMC3897280/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3897280</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24257421" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24257421</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>22.</dt><dd><div class="bk_ref" id="article-161800.r22">Maldonado YA, Read JS., COMMITTEE ON INFECTIOUS DISEASES. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. <span><span class="ref-journal">Pediatrics. </span>2017 Feb;<span class="ref-vol">139</span>(2)</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28138010" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28138010</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>23.</dt><dd><div class="bk_ref" id="article-161800.r23">Hrnjaković-Cvjetković I, Jerant-Patić V, Cvjetković D, Mrdja E, Milosević V. [Congenital toxoplasmosis]. <span><span class="ref-journal">Med Pregl. </span>1998 Mar-Apr;<span class="ref-vol">51</span>(3-4):140-5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9611957" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9611957</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>24.</dt><dd><div class="bk_ref" id="article-161800.r24">Charlier C, Disson O, Lecuit M. Maternal-neonatal listeriosis. <span><span class="ref-journal">Virulence. </span>2020 Dec;<span class="ref-vol">11</span>(1):391-397.</span> [<a href="/pmc/articles/PMC7199740/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7199740</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32363991" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32363991</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>25.</dt><dd><div class="bk_ref" id="article-161800.r25">Committee on Infectious Diseases; Committee on Nutrition; American Academy of Pediatrics. Consumption of raw or unpasteurized milk and milk products by pregnant women and children. <span><span class="ref-journal">Pediatrics. </span>2014 Jan;<span class="ref-vol">133</span>(1):175-9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24344105" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24344105</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>26.</dt><dd><div class="bk_ref" id="article-161800.r26">Bergholz TM, den Bakker HC, Fortes ED, Boor KJ, Wiedmann M. Salt stress phenotypes in Listeria monocytogenes vary by genetic lineage and temperature. <span><span class="ref-journal">Foodborne Pathog Dis. </span>2010 Dec;<span class="ref-vol">7</span>(12):1537-49.</span> [<a href="/pmc/articles/PMC3022828/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3022828</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20707723" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20707723</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>27.</dt><dd><div class="bk_ref" id="article-161800.r27">Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M., MONALISA study group. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. <span><span class="ref-journal">Lancet Infect Dis. </span>2017 May;<span class="ref-vol">17</span>(5):510-519.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28139432" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28139432</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>28.</dt><dd><div class="bk_ref" id="article-161800.r28">Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL, Cohen BJ, Mortimer PP, Pereira MS. Human parvovirus, the cause of erythema infectiosum (fifth disease)? <span><span class="ref-journal">Lancet. </span>1983 Jun 18;<span class="ref-vol">1</span>(8338):1378.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6134148" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 6134148</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>29.</dt><dd><div class="bk_ref" id="article-161800.r29">Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. <span><span class="ref-journal">Prenat Diagn. </span>2004 Jul;<span class="ref-vol">24</span>(7):513-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15300741" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15300741</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>30.</dt><dd><div class="bk_ref" id="article-161800.r30">Pasquinelli G, Bonvicini F, Foroni L, Salfi N, Gallinella G. Placental endothelial cells can be productively infected by Parvovirus B19. <span><span class="ref-journal">J Clin Virol. </span>2009 Jan;<span class="ref-vol">44</span>(1):33-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19058999" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19058999</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>31.</dt><dd><div class="bk_ref" id="article-161800.r31">Ou AC, Zimmerman LA, Alexander JP, Crowcroft NS, O'Connor PM, Knapp JK. Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022. <span><span class="ref-journal">MMWR Morb Mortal Wkly Rep. </span>2024 Feb 29;<span class="ref-vol">73</span>(8):162-167.</span> [<a href="/pmc/articles/PMC10907039/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC10907039</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38421933" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38421933</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>32.</dt><dd><div class="bk_ref" id="article-161800.r32">Lazar M, Perelygina L, Martines R, Greer P, Paddock CD, Peltecu G, Lupulescu E, Icenogle J, Zaki SR. Immunolocalization and Distribution of Rubella Antigen in Fatal Congenital Rubella Syndrome. <span><span class="ref-journal">EBioMedicine. </span>2016 Jan;<span class="ref-vol">3</span>:86-92.</span> [<a href="/pmc/articles/PMC4739417/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4739417</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26870820" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26870820</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>33.</dt><dd><div class="bk_ref" id="article-161800.r33">Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. <span><span class="ref-journal">Lancet. </span>1982 Oct 09;<span class="ref-vol">2</span>(8302):781-4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6126663" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 6126663</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>34.</dt><dd><div class="bk_ref" id="article-161800.r34">Lebo EJ, Kruszon-Moran DM, Marin M, Bellini WJ, Schmid S, Bialek SR, Wallace GS, McLean HQ. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010. <span><span class="ref-journal">Open Forum Infect Dis. </span>2015 Jan;<span class="ref-vol">2</span>(1):ofv006.</span> [<a href="/pmc/articles/PMC4438887/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4438887</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26034757" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26034757</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>35.</dt><dd><div class="bk_ref" id="article-161800.r35">Lamont RF, Sobel JD, Carrington D, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, Romero R. Varicella-zoster virus (chickenpox) infection in pregnancy. <span><span class="ref-journal">BJOG. </span>2011 Sep;<span class="ref-vol">118</span>(10):1155-62.</span> [<a href="/pmc/articles/PMC3155623/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3155623</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21585641" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 21585641</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>36.</dt><dd><div class="bk_ref" id="article-161800.r36">Tan MP, Koren G. Chickenpox in pregnancy: revisited. <span><span class="ref-journal">Reprod Toxicol. </span>2006 May;<span class="ref-vol">21</span>(4):410-20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15979274" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15979274</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>37.</dt><dd><div class="bk_ref" id="article-161800.r37">Ahn KH, Park YJ, Hong SC, Lee EH, Lee JS, Oh MJ, Kim HJ. Congenital varicella syndrome: A systematic review. <span><span class="ref-journal">J Obstet Gynaecol. </span>2016 Jul;<span class="ref-vol">36</span>(5):563-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26965725" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26965725</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>38.</dt><dd><div class="bk_ref" id="article-161800.r38">Chiu CF, Chu LW, Liao IC, Simanjuntak Y, Lin YL, Juan CC, Ping YH. The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier. <span><span class="ref-journal">Front Microbiol. </span>2020;<span class="ref-vol">11</span>:214.</span> [<a href="/pmc/articles/PMC7044130/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7044130</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32153526" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32153526</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>39.</dt><dd><div class="bk_ref" id="article-161800.r39">Moseley P, Bamford A, Eisen S, Lyall H, Kingston M, Thorne C, Piñera C, Rabie H, Prendergast AJ, Kadambari S. Resurgence of congenital syphilis: new strategies against an old foe. <span><span class="ref-journal">Lancet Infect Dis. </span>2024 Jan;<span class="ref-vol">24</span>(1):e24-e35.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37604180" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37604180</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>40.</dt><dd><div class="bk_ref" id="article-161800.r40">Korenromp EL, Rowley J, Alonso M, Mello MB, Wijesooriya NS, Mahiané SG, Ishikawa N, Le LV, Newman-Owiredu M, Nagelkerke N, Newman L, Kamb M, Broutet N, Taylor MM. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. <span><span class="ref-journal">PLoS One. </span>2019;<span class="ref-vol">14</span>(2):e0211720.</span> [<a href="/pmc/articles/PMC6392238/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6392238</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30811406" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30811406</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>41.</dt><dd><div class="bk_ref" id="article-161800.r41">Cejtin HE, Warren EF, Guidry T, Boss K, Becht A, Tabidze I. Notes from the Field: Diagnosis of Congenital Syphilis and Syphilis Among Females of Reproductive Age Before and During the COVID-19 Pandemic - Chicago, 2015-2022. <span><span class="ref-journal">MMWR Morb Mortal Wkly Rep. </span>2023 Nov 24;<span class="ref-vol">72</span>(47):1288-1289.</span> [<a href="/pmc/articles/PMC10685382/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC10685382</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37991996" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37991996</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>42.</dt><dd><div class="bk_ref" id="article-161800.r42">Dubey JP, Murata FHA, Cerqueira-Cézar CK, Kwok OCH, Villena I. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. <span><span class="ref-journal">Parasitology. </span>2021 Oct;<span class="ref-vol">148</span>(12):1406-1416.</span> [<a href="/pmc/articles/PMC11010219/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC11010219</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34254575" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34254575</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>43.</dt><dd><div class="bk_ref" id="article-161800.r43">Picone O, Fuchs F, Benoist G, Binquet C, Kieffer F, Wallon M, Wehbe K, Mandelbrot L, Villena I. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF. <span><span class="ref-journal">J Gynecol Obstet Hum Reprod. </span>2020 Sep;<span class="ref-vol">49</span>(7):101814.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32428782" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32428782</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>44.</dt><dd><div class="bk_ref" id="article-161800.r44">Silk BJ, Date KA, Jackson KA, Pouillot R, Holt KG, Graves LM, Ong KL, Hurd S, Meyer R, Marcus R, Shiferaw B, Norton DM, Medus C, Zansky SM, Cronquist AB, Henao OL, Jones TF, Vugia DJ, Farley MM, Mahon BE. Invasive listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009: further targeted prevention needed for higher-risk groups. <span><span class="ref-journal">Clin Infect Dis. </span>2012 Jun;<span class="ref-vol">54 Suppl 5</span>:S396-404.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22572660" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22572660</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>45.</dt><dd><div class="bk_ref" id="article-161800.r45">Attwood LO, Holmes NE, Hui L. Identification and management of congenital parvovirus B19 infection. <span><span class="ref-journal">Prenat Diagn. </span>2020 Dec;<span class="ref-vol">40</span>(13):1722-1731.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32860469" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32860469</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>46.</dt><dd><div class="bk_ref" id="article-161800.r46">Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. <span><span class="ref-journal">Bull World Health Organ. </span>1997;<span class="ref-vol">75</span>(1):55-68.</span> [<a href="/pmc/articles/PMC2486980/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2486980</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9141751" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9141751</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>47.</dt><dd><div class="bk_ref" id="article-161800.r47">Vynnycky E, Knapp JK, Papadopoulos T, Cutts FT, Hachiya M, Miyano S, Reef SE. Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019. <span><span class="ref-journal">Int J Infect Dis. </span>2023 Dec;<span class="ref-vol">137</span>:149-156.</span> [<a href="/pmc/articles/PMC10689248/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC10689248</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37690575" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37690575</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>48.</dt><dd><div class="bk_ref" id="article-161800.r48">Winter AK, Moss WJ. Rubella. <span><span class="ref-journal">Lancet. </span>2022 Apr 02;<span class="ref-vol">399</span>(10332):1336-1346.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35367004" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 35367004</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>49.</dt><dd><div class="bk_ref" id="article-161800.r49">Hills SL, Fischer M, Petersen LR. Epidemiology of Zika Virus Infection. <span><span class="ref-journal">J Infect Dis. </span>2017 Dec 16;<span class="ref-vol">216</span>(suppl_10):S868-S874.</span> [<a href="/pmc/articles/PMC5853392/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5853392</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29267914" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29267914</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>50.</dt><dd><div class="bk_ref" id="article-161800.r50">Marbán-Castro E, Goncé A, Fumadó V, Romero-Acevedo L, Bardají A. Zika virus infection in pregnant women and their children: A review. <span><span class="ref-journal">Eur J Obstet Gynecol Reprod Biol. </span>2021 Oct;<span class="ref-vol">265</span>:162-168.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34508989" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34508989</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>51.</dt><dd><div class="bk_ref" id="article-161800.r51">França GV, Schuler-Faccini L, Oliveira WK, Henriques CM, Carmo EH, Pedi VD, Nunes ML, Castro MC, Serruya S, Silveira MF, Barros FC, Victora CG. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. <span><span class="ref-journal">Lancet. </span>2016 Aug 27;<span class="ref-vol">388</span>(10047):891-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27372398" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27372398</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>52.</dt><dd><div class="bk_ref" id="article-161800.r52">Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. <span><span class="ref-journal">Obstet Gynecol. </span>2015 Jun;<span class="ref-vol">125</span>(6):1510-1525.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26000539" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26000539</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>53.</dt><dd><div class="bk_ref" id="article-161800.r53">Puopolo KM, Benitz WE, Zaoutis TE., COMMITTEE ON FETUS AND NEWBORN. COMMITTEE ON INFECTIOUS DISEASES. Management of Neonates Born at ≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. <span><span class="ref-journal">Pediatrics. </span>2018 Dec;<span class="ref-vol">142</span>(6)</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30455342" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30455342</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>54.</dt><dd><div class="bk_ref" id="article-161800.r54">Devakumar D, Bamford A, Ferreira MU, Broad J, Rosch RE, Groce N, Breuer J, Cardoso MA, Copp AJ, Alexandre P, Rodrigues LC, Abubakar I. Infectious causes of microcephaly: epidemiology, pathogenesis, diagnosis, and management. <span><span class="ref-journal">Lancet Infect Dis. </span>2018 Jan;<span class="ref-vol">18</span>(1):e1-e13.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28844634" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28844634</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>55.</dt><dd><div class="bk_ref" id="article-161800.r55">Sasidharan CK, Anoop P. Congenital varicella syndrome. <span><span class="ref-journal">Indian J Pediatr. </span>2003 Jan;<span class="ref-vol">70</span>(1):101-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12619963" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12619963</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>56.</dt><dd><div class="bk_ref" id="article-161800.r56">Dreher AM, Arora N, Fowler KB, Novak Z, Britt WJ, Boppana SB, Ross SA. Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. <span><span class="ref-journal">J Pediatr. </span>2014 Apr;<span class="ref-vol">164</span>(4):855-9.</span> [<a href="/pmc/articles/PMC3982912/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3982912</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24433826" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24433826</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>57.</dt><dd><div class="bk_ref" id="article-161800.r57">Mehta V, Balachandran C, Lonikar V. Blueberry muffin baby: a pictoral differential diagnosis. <span><span class="ref-journal">Dermatol Online J. </span>2008 Feb 28;<span class="ref-vol">14</span>(2):8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18700111" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18700111</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>58.</dt><dd><div class="bk_ref" id="article-161800.r58">Timoney MT, Fine SM, Vail R, McGowan JP, Merrick ST, Radix A, Hoffmann CJ, Gonzalez CJ. <span class="ref-journal">HIV Testing During Pregnancy, at Delivery, and Postpartum [Internet].</span> Johns Hopkins University; Baltimore (MD): Sep, 2022. [<a href="https://pubmed.ncbi.nlm.nih.gov/32804447" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32804447</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>59.</dt><dd><div class="bk_ref" id="article-161800.r59">Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6. <span><span class="ref-journal">Obstet Gynecol. </span>2023 Sep 01;<span class="ref-vol">142</span>(3):745-759.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37590986" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37590986</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>60.</dt><dd><div class="bk_ref" id="article-161800.r60">US Preventive Services Task Force. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Syphilis Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement. <span><span class="ref-journal">JAMA. </span>2018 Sep 04;<span class="ref-vol">320</span>(9):911-917.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30193283" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30193283</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>61.</dt><dd><div class="bk_ref" id="article-161800.r61">de Jong EP, Vossen AC, Walther FJ, Lopriore E. How to use... neonatal TORCH testing. <span><span class="ref-journal">Arch Dis Child Educ Pract Ed. </span>2013 Jun;<span class="ref-vol">98</span>(3):93-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23470252" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23470252</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>62.</dt><dd><div class="bk_ref" id="article-161800.r62">Fitzpatrick D, Holmes NE, Hui L. A systematic review of maternal TORCH serology as a screen for suspected fetal infection. <span><span class="ref-journal">Prenat Diagn. </span>2022 Jan;<span class="ref-vol">42</span>(1):87-96.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34893980" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34893980</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>63.</dt><dd><div class="bk_ref" id="article-161800.r63">Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. <span><span class="ref-journal">MMWR Recomm Rep. </span>2021 Jul 23;<span class="ref-vol">70</span>(4):1-187.</span> [<a href="/pmc/articles/PMC8344968/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8344968</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34292926" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34292926</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>64.</dt><dd><div class="bk_ref" id="article-161800.r64">Fang J, Partridge E, Bautista GM, Sankaran D. Congenital Syphilis Epidemiology, Prevention, and Management in the United States: A 2022 Update. <span><span class="ref-journal">Cureus. </span>2022 Dec;<span class="ref-vol">14</span>(12):e33009.</span> [<a href="/pmc/articles/PMC9879571/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC9879571</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36712768" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 36712768</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>65.</dt><dd><div class="bk_ref" id="article-161800.r65">Lopata SM, McNeer E, Dudley JA, Wester C, Cooper WO, Carlucci JG, Espinosa CM, Dupont W, Patrick SW. Hepatitis C Testing Among Perinatally Exposed Infants. <span><span class="ref-journal">Pediatrics. </span>2020 Mar;<span class="ref-vol">145</span>(3)</span> [<a href="/pmc/articles/PMC7049945/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7049945</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32060140" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32060140</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>66.</dt><dd><div class="bk_ref" id="article-161800.r66">Committee Opinion No. 614: Management of pregnant women with presumptive exposure to Listeria monocytogenes. <span><span class="ref-journal">Obstet Gynecol. </span>2014 Dec;<span class="ref-vol">124</span>(6):1241-1244.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25411758" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25411758</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>67.</dt><dd><div class="bk_ref" id="article-161800.r67">Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, Daly K, Doutré S, Gibson L, Giles ML, Greenlee J, Hamilton ST, Harrison GJ, Hui L, Jones CA, Palasanthiran P, Schleiss MR, Shand AW, van Zuylen WJ. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. <span><span class="ref-journal">Lancet Infect Dis. </span>2017 Jun;<span class="ref-vol">17</span>(6):e177-e188.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28291720" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28291720</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>68.</dt><dd><div class="bk_ref" id="article-161800.r68">Aldè M, Binda S, Primache V, Pellegrinelli L, Pariani E, Pregliasco F, Di Berardino F, Cantarella G, Ambrosetti U. Congenital Cytomegalovirus and Hearing Loss: The State of the Art. <span><span class="ref-journal">J Clin Med. </span>2023 Jul 03;<span class="ref-vol">12</span>(13)</span> [<a href="/pmc/articles/PMC10342520/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC10342520</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37445500" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37445500</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>69.</dt><dd><div class="bk_ref" id="article-161800.r69">Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. <span><span class="ref-journal">MMWR Recomm Rep. </span>2001 Jul 13;<span class="ref-vol">50</span>(RR-12):1-23.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11475328" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11475328</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>70.</dt><dd><div class="bk_ref" id="article-161800.r70">Reef SE, Plotkin S, Cordero JF, Katz M, Cooper L, Schwartz B, Zimmerman-Swain L, Danovaro-Holliday MC, Wharton M. Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. <span><span class="ref-journal">Clin Infect Dis. </span>2000 Jul;<span class="ref-vol">31</span>(1):85-95.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10913402" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10913402</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>71.</dt><dd><div class="bk_ref" id="article-161800.r71">Alkalay AL, Pomerance JJ, Rimoin DL. Fetal varicella syndrome. <span><span class="ref-journal">J Pediatr. </span>1987 Sep;<span class="ref-vol">111</span>(3):320-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3625399" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3625399</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>72.</dt><dd><div class="bk_ref" id="article-161800.r72">Oduyebo T, Polen KD, Walke HT, Reagan-Steiner S, Lathrop E, Rabe IB, Kuhnert-Tallman WL, Martin SW, Walker AT, Gregory CJ, Ades EW, Carroll DS, Rivera M, Perez-Padilla J, Gould C, Nemhauser JB, Ben Beard C, Harcourt JL, Viens L, Johansson M, Ellington SR, Petersen E, Smith LA, Reichard J, Munoz-Jordan J, Beach MJ, Rose DA, Barzilay E, Noonan-Smith M, Jamieson DJ, Zaki SR, Petersen LR, Honein MA, Meaney-Delman D. Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017. <span><span class="ref-journal">MMWR Morb Mortal Wkly Rep. </span>2017 Jul 28;<span class="ref-vol">66</span>(29):781-793.</span> [<a href="/pmc/articles/PMC5657812/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5657812</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28749921" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28749921</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>73.</dt><dd><div class="bk_ref" id="article-161800.r73">Mercado M, Ailes EC, Daza M, Tong VT, Osorio J, Valencia D, Rico A, Galang RR, González M, Ricaldi JN, Anderson KN, Kamal N, Thomas JD, Villanueva J, Burkel VK, Meaney-Delman D, Gilboa SM, Honein MA, Jamieson DJ, Ospina ML. Zika virus detection in amniotic fluid and Zika-associated birth defects. <span><span class="ref-journal">Am J Obstet Gynecol. </span>2020 Jun;<span class="ref-vol">222</span>(6):610.e1-610.e13.</span> [<a href="/pmc/articles/PMC7477618/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7477618</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31954155" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31954155</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>74.</dt><dd><div class="bk_ref" id="article-161800.r74">Viens LJ, Fleck-Derderian S, Baez-Santiago MA, Oduyebo T, Broussard CS, Khan S, Jones AM, Meaney-Delman D. Role of Prenatal Ultrasonography and Amniocentesis in the Diagnosis of Congenital Zika Syndrome: A Systematic Review. <span><span class="ref-journal">Obstet Gynecol. </span>2020 May;<span class="ref-vol">135</span>(5):1185-1197.</span> [<a href="/pmc/articles/PMC8689815/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8689815</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32282593" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32282593</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>75.</dt><dd><div class="bk_ref" id="article-161800.r75">Russell K, Oliver SE, Lewis L, Barfield WD, Cragan J, Meaney-Delman D, Staples JE, Fischer M, Peacock G, Oduyebo T, Petersen EE, Zaki S, Moore CA, Rasmussen SA., Contributors. Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016. <span><span class="ref-journal">MMWR Morb Mortal Wkly Rep. </span>2016 Aug 26;<span class="ref-vol">65</span>(33):870-878.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27559830" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27559830</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>76.</dt><dd><div class="bk_ref" id="article-161800.r76">Management of Genital Herpes in Pregnancy: ACOG Practice Bulletinacog Practice Bulletin, Number 220. <span><span class="ref-journal">Obstet Gynecol. </span>2020 May;<span class="ref-vol">135</span>(5):e193-e202.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32332414" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32332414</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>77.</dt><dd><div class="bk_ref" id="article-161800.r77">Kimberlin DW, Baley J., Committee on infectious diseases. Committee on fetus and newborn. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. <span><span class="ref-journal">Pediatrics. </span>2013 Feb;<span class="ref-vol">131</span>(2):e635-46.</span> [<a href="/pmc/articles/PMC3557411/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3557411</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23359576" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23359576</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>78.</dt><dd><div class="bk_ref" id="article-161800.r78">Pantell RH, Roberts KB, Adams WG, Dreyer BP, Kuppermann N, O'Leary ST, Okechukwu K, Woods CR., SUBCOMMITTEE ON FEBRILE INFANTS. Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old. <span><span class="ref-journal">Pediatrics. </span>2021 Aug;<span class="ref-vol">148</span>(2)</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34281996" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34281996</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>79.</dt><dd><div class="bk_ref" id="article-161800.r79">Choodinatha HK, Jeon MR, Choi BY, Lee KN, Kim HJ, Park JY. Cytomegalovirus infection during pregnancy. <span><span class="ref-journal">Obstet Gynecol Sci. </span>2023 Nov;<span class="ref-vol">66</span>(6):463-476.</span> [<a href="/pmc/articles/PMC10663402/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC10663402</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37537975" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37537975</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>80.</dt><dd><div class="bk_ref" id="article-161800.r80">D'Antonio F, Marinceu D, Prasad S, Khalil A. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis. <span><span class="ref-journal">Ultrasound Obstet Gynecol. </span>2023 Apr;<span class="ref-vol">61</span>(4):436-444.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36484439" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 36484439</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>81.</dt><dd><div class="bk_ref" id="article-161800.r81">Luck SE, Wieringa JW, Blázquez-Gamero D, Henneke P, Schuster K, Butler K, Capretti MG, Cilleruelo MJ, Curtis N, Garofoli F, Heath P, Iosifidis E, Klein N, Lombardi G, Lyall H, Nieminen T, Pajkrt D, Papaevangelou V, Posfay-Barbe K, Puhakka L, Roilides E, Rojo P, Saavedra-Lozano J, Shah T, Sharland M, Saxen H, Vossen ACTM., ESPID Congenital CMV Group Meeting, Leipzig 2015. Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management. <span><span class="ref-journal">Pediatr Infect Dis J. </span>2017 Dec;<span class="ref-vol">36</span>(12):1205-1213.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29140947" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29140947</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>82.</dt><dd><div class="bk_ref" id="article-161800.r82">Centers for Disease Control and Prevention (CDC). Updated recommendations for use of VariZIG--United States, 2013. <span><span class="ref-journal">MMWR Morb Mortal Wkly Rep. </span>2013 Jul 19;<span class="ref-vol">62</span>(28):574-6.</span> [<a href="/pmc/articles/PMC4604813/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4604813</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23863705" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23863705</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>83.</dt><dd><div class="bk_ref" id="article-161800.r83">Bernatchez JA, Tran LT, Li J, Luan Y, Siqueira-Neto JL, Li R. Drugs for the Treatment of Zika Virus Infection. <span><span class="ref-journal">J Med Chem. </span>2020 Jan 23;<span class="ref-vol">63</span>(2):470-489.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31549836" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31549836</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>84.</dt><dd><div class="bk_ref" id="article-161800.r84">Cyr J, Langley A, Demellawy DE, Ramien M. A neonate with Langerhans cell histiocytosis presenting as blueberry muffin rash: Case report and review of the literature. <span><span class="ref-journal">SAGE Open Med Case Rep. </span>2020;<span class="ref-vol">8</span>:2050313X20919616.</span> [<a href="/pmc/articles/PMC7273623/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7273623</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32547754" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32547754</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>85.</dt><dd><div class="bk_ref" id="article-161800.r85">Wozniak PS, Cantey JB, Zeray F, Leos NK, Michelow IC, Sheffield JS, Wendel GD, Sánchez PJ. The Mortality of Congenital Syphilis. <span><span class="ref-journal">J Pediatr. </span>2023 Dec;<span class="ref-vol">263</span>:113650.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37536483" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37536483</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>86.</dt><dd><div class="bk_ref" id="article-161800.r86">Lago EG, Vaccari A, Fiori RM. Clinical features and follow-up of congenital syphilis. <span><span class="ref-journal">Sex Transm Dis. </span>2013 Feb;<span class="ref-vol">40</span>(2):85-94.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23324972" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23324972</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>87.</dt><dd><div class="bk_ref" id="article-161800.r87">Jhaveri R. Diagnosis and management of hepatitis C virus-infected children. <span><span class="ref-journal">Pediatr Infect Dis J. </span>2011 Nov;<span class="ref-vol">30</span>(11):983-5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21997662" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 21997662</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>88.</dt><dd><div class="bk_ref" id="article-161800.r88">Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. <span><span class="ref-journal">Lancet. </span>1986 Feb 01;<span class="ref-vol">1</span>(8475):254-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2868264" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 2868264</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>89.</dt><dd><div class="bk_ref" id="article-161800.r89">Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. <span><span class="ref-journal">Pediatrics. </span>1980 Nov;<span class="ref-vol">66</span>(5):767-74.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7432882" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7432882</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>90.</dt><dd><div class="bk_ref" id="article-161800.r90">Wallon M, Garweg JG, Abrahamowicz M, Cornu C, Vinault S, Quantin C, Bonithon-Kopp C, Picot S, Peyron F, Binquet C. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. <span><span class="ref-journal">Pediatrics. </span>2014 Mar;<span class="ref-vol">133</span>(3):e601-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24534412" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24534412</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>91.</dt><dd><div class="bk_ref" id="article-161800.r91">Mylonakis E, Paliou M, Hohmann EL, Calderwood SB, Wing EJ. Listeriosis during pregnancy: a case series and review of 222 cases. <span><span class="ref-journal">Medicine (Baltimore). </span>2002 Jul;<span class="ref-vol">81</span>(4):260-9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12169881" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12169881</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>92.</dt><dd><div class="bk_ref" id="article-161800.r92">Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA, Peckham CS. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. <span><span class="ref-journal">Clin Infect Dis. </span>2013 May;<span class="ref-vol">56</span>(9):1232-9.</span> [<a href="/pmc/articles/PMC3616516/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3616516</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23334811" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23334811</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>93.</dt><dd><div class="bk_ref" id="article-161800.r93">Lanzieri TM, Caviness AC, Blum P, Demmler-Harrison G., Congenital Cytomegalovirus Longitudinal Study Group. Progressive, Long-Term Hearing Loss in Congenital CMV Disease After Ganciclovir Therapy. <span><span class="ref-journal">J Pediatric Infect Dis Soc. </span>2022 Jan 27;<span class="ref-vol">11</span>(1):16-23.</span> [<a href="/pmc/articles/PMC9590555/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC9590555</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34718680" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34718680</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>94.</dt><dd><div class="bk_ref" id="article-161800.r94">Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, DeBiasi RL, Han JY, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths PD, Luck S, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Woods CR, Sabo DL, Aban I, Kuo H, James SH, Prichard MN, Griffin J, Giles D, Acosta EP, Whitley RJ., National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. <span><span class="ref-journal">N Engl J Med. </span>2015 Mar 05;<span class="ref-vol">372</span>(10):933-43.</span> [<a href="/pmc/articles/PMC4401811/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4401811</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25738669" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25738669</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>95.</dt><dd><div class="bk_ref" id="article-161800.r95">Lassen J, Jensen AK, Bager P, Pedersen CB, Panum I, Nørgaard-Pedersen B, Aaby P, Wohlfahrt J, Melbye M. Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study. <span><span class="ref-journal">Am J Epidemiol. </span>2012 Nov 01;<span class="ref-vol">176</span>(9):803-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23051601" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23051601</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>96.</dt><dd><div class="bk_ref" id="article-161800.r96">Xiong YQ, Tan J, Liu YM, He Q, Li L, Zou K, Sun X. The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis. <span><span class="ref-journal">J Clin Virol. </span>2019 May;<span class="ref-vol">114</span>:12-20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30897374" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30897374</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>97.</dt><dd><div class="bk_ref" id="article-161800.r97">Bascietto F, Liberati M, Murgano D, Buca D, Iacovelli A, Flacco ME, Manzoli L, Familiari A, Scambia G, D'Antonio F. Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis. <span><span class="ref-journal">Ultrasound Obstet Gynecol. </span>2018 Nov;<span class="ref-vol">52</span>(5):569-576.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29785793" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29785793</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>98.</dt><dd><div class="bk_ref" id="article-161800.r98">Forrest JM, Turnbull FM, Sholler GF, Hawker RE, Martin FJ, Doran TT, Burgess MA. Gregg's congenital rubella patients 60 years later. <span><span class="ref-journal">Med J Aust. </span>2002 Dec 2-16;<span class="ref-vol">177</span>(11-12):664-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12463994" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12463994</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>99.</dt><dd><div class="bk_ref" id="article-161800.r99">McIntosh ED, Menser MA. A fifty-year follow-up of congenital rubella. <span><span class="ref-journal">Lancet. </span>1992 Aug 15;<span class="ref-vol">340</span>(8816):414-5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1353568" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1353568</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>100.</dt><dd><div class="bk_ref" id="article-161800.r100">Schulze A, Dietzsch HJ. The natural history of varicella embryopathy: a 25-year follow-up. <span><span class="ref-journal">J Pediatr. </span>2000 Dec;<span class="ref-vol">137</span>(6):871-4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11113846" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11113846</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>101.</dt><dd><div class="bk_ref" id="article-161800.r101">Nielsen-Saines K, Brasil P, Kerin T, Vasconcelos Z, Gabaglia CR, Damasceno L, Pone M, Abreu de Carvalho LM, Pone SM, Zin AA, Tsui I, Salles TRS, da Cunha DC, Costa RP, Malacarne J, Reis AB, Hasue RH, Aizawa CYP, Genovesi FF, Einspieler C, Marschik PB, Pereira JP, Gaw SL, Adachi K, Cherry JD, Xu Z, Cheng G, Moreira ME. Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children. <span><span class="ref-journal">Nat Med. </span>2019 Aug;<span class="ref-vol">25</span>(8):1213-1217.</span> [<a href="/pmc/articles/PMC6689256/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6689256</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31285631" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31285631</span></a>]</div></dd></dl></dl></div><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_top_margin">
|
|
<b>Disclosure: </b>James McCluskey declares no relevant financial relationships with ineligible companies.</p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_top_margin">
|
|
<b>Disclosure: </b>Alice Sato declares no relevant financial relationships with ineligible companies.</p></div></dd></dl></dl></div></div></div><div class="fm-sec"><h2 id="_NBK604195_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><p class="contrib-group"><h4>Authors</h4><span itemprop="author">James M. McCluskey</span><sup>1</sup>; <span itemprop="author">Alice I. Sato</span><sup>2</sup>.</p><h4>Affiliations</h4><div class="affiliation"><sup>1</sup> University of Nebraska Medical Center</div><div class="affiliation"><sup>2</sup> UNMC</div><h3>Publication History</h3><p class="small">Last Update: <span itemprop="dateModified">August 16, 2024</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 2025, StatPearls Publishing LLC.<p class="small">
|
|
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
|
|
(<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=uri">
|
|
http://creativecommons.org/licenses/by-nc-nd/4.0/
|
|
</a>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
|
|
</p></div></div><h3>Publisher</h3><p><a href="https://www.statpearls.com/" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">StatPearls Publishing</a>, Treasure Island (FL)</p><h3>NLM Citation</h3><p>McCluskey JM, Sato AI. Vertical Transplacental Infections. [Updated 2024 Aug 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. <span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"></div><div class="small-screen-next"></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|